<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_a9f2f3V">A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>PhD NP</roleName><forename type="first">Linda</forename><forename type="middle">G</forename><surname>Park</surname></persName>
							<email>linda.park@ucsf.edu</email>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Jill</forename><surname>Howie-Esquivel</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Kathleen</forename><surname>Dracup</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Post-doctoral Fellow Division of Geriatrics , University of California , San Francisco VA</note>
								<orgName type="department">Post-doctoral Fellow Division of Geriatrics</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>San Francisco VA</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Medical Center , California , USA</note>
								<orgName type="department">Medical Center</orgName>
								<address>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">School of Nursing , University of California , San Francisco , California , USA</note>
								<orgName type="department">School of Nursing</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Professor Emeritus and Dean Emeritus School of Nursing , University of California , San Francisco , California , USA</note>
								<orgName type="department">Professor Emeritus and Dean Emeritus School of Nursing</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_AhEEhav">A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">AEE1C0A6C10732702F1197367D93252C</idno>
					<idno type="DOI">10.1111/jan.12400</idno>
					<note type="submission">Accepted for publication 22 February 2014</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T09:41+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_gSE74jq">medication adherence</term>
					<term xml:id="_EUTNYMU">mobile phone</term>
					<term xml:id="_yKz5URC">nursing</term>
					<term xml:id="_wNTNdVY">short message service (SMS)</term>
					<term xml:id="_vudfEuy">text messaging</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_VYxVqN7"><p xml:id="_EQfzrMW"><s xml:id="_eV67q8x">Aims.</s><s xml:id="_FVNWw6K">To evaluate the characteristics and efficacy of mobile phone interventions to improve medication adherence.</s><s xml:id="_rP6yT2x">Secondary aims are to explore participants' acceptability and satisfaction with mobile phone interventions and to evaluate the selected studies in terms of study rigour, impact, cost and resource feasibility, generalizability and implications for nursing practice and research.</s><s xml:id="_JEgjqed">Background.</s><s xml:id="_3A4RE5V">Medication non-adherence is a major global challenge.</s><s xml:id="_Yub2XpC">Mobile phones are the most commonly used form of technology worldwide and have the potential to promote medication adherence.</s><s xml:id="_zaFezZG">Design.</s><s xml:id="_UBASCCe">Guidelines from the Centre for Reviews and Dissemination were followed for this systematic review.</s><s xml:id="_qND7U6h">Data Sources.</s><s xml:id="_2MRhSYN">A comprehensive search of databases (PubMed, Web of Science, CINAHL, PsycInfo, Google Chrome and Cochrane) and bibliographies from related articles was performed from January 2002-January 2013 to identify the included studies.</s><s xml:id="_4XNrH7e">Review Methods.</s><s xml:id="_Pbfj6Rq">A quantitative systematic review without meta-analysis was conducted and the selected studies were critically evaluated to extract and summarize pertinent characteristics and outcomes.</s><s xml:id="_cABTVvb">Results.</s><s xml:id="_3VMxN45">The literature search produced 29 quantitative research studies related to mobile phones and medication adherence.</s><s xml:id="_Dvu4RHw">The studies were conducted for prevention purposes as well as management of acute and chronic illnesses.</s><s xml:id="_CT25kDY">All of the studies used text messaging.</s><s xml:id="_sscQXhn">Eighteen studies found significant improvement in medication adherence.</s><s xml:id="_gpRATrF">Conclusion.</s><s xml:id="_MfQ2dVa">While the majority of investigators found improvement in medication adherence, long-term studies characterized by rigorous research methodologies, appropriate statistical and economic analyses and the test of theory-based interventions are needed to determine the efficacy of mobile phones to influence medication adherence.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="20" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="21" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="22" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_demEguM">Introduction</head><p xml:id="_Rgch8Mn"><s xml:id="_zJHTjJ8">Medication non-adherence is a major global challenge <ref type="bibr">[World Health Organization (WHO) 2003</ref>].</s><s xml:id="_PWp5wBP">More than half of Americans with chronic diseases do not take any or all of their medications correctly <ref type="bibr" target="#b33">(Osterberg &amp; Blaschke 2005)</ref>.</s><s xml:id="_Q9BYa2E">In developing countries with limited resources and access to health care, medication non-adherence is assumed to have even greater magnitude and impact <ref type="bibr">(WHO 2003)</ref>.</s><s xml:id="_tSTzSg3">A strong association between medication adherence and clinical outcomes such as rehospitalization, morbidity and mortality has been demonstrated in observational studies <ref type="bibr">(Smith et al. 2006</ref>).</s><s xml:id="_2v7eAeA">In addition, medication non-adherence results in an estimated $290 billion in US healthcare costs <ref type="bibr">(New England Health Institute 2009)</ref>.</s></p><p xml:id="_d86ukf8"><s xml:id="_jNKfcaq">Behavioural change interventions have attempted to promote medication adherence over many decades as reported in a Cochrane review of 83 studies; however, even the most efficacious interventions did not result in large improvements in adherence and treatment outcomes <ref type="bibr" target="#b16">(Haynes et al. 2008)</ref>.</s><s xml:id="_RKaYfmB">The factors that influence medication adherence behaviour are complex and unique to each individual, thereby requiring numerous multifactorial strategies to remove barriers and promote adherence <ref type="bibr" target="#b3">(Brown &amp; Bussell 2011)</ref>.</s><s xml:id="_MGTVdQt">In the recent decade, novel behavioural interventions have introduced the use of technology by applying mobile health (mHealth) solutions to enhance adherence.</s><s xml:id="_TkKsVWb">Mobile health can facilitate the implementation of these behavioural strategies to provide meaningful impact on primary and secondary prevention of chronic diseases.</s></p><p xml:id="_MvRXkKa"><s xml:id="_KUAsuKJ">Technology may provide a practical and inexpensive means to promote medication adherence.</s><s xml:id="_B2UDxHZ">The evolution of mHealth has taken shape in the past decade and refers to the use of mobile devices that are used to promote health.</s><s xml:id="_GpWJHCW">Mobile phones are the most commonly used form of technology worldwide (International Telecommunication Union 2011) and have the greatest potential to influence large populations.</s><s xml:id="_vDReEUa">mHealth has '. . . the potential to advance research, prevent disease, enhance diagnostics, improve treatment, reduce disparities, increase access to health services and lower healthcare costs in ways previously unimaginable' <ref type="bibr">(Nilsen et al. 2012, p. 6)</ref>.</s><s xml:id="_YChQbvP">The growth of mobile phones over the past decade has been astounding with worldwide mobile phone subscriptions growing from 12Á4 million to 5Á9 billion in 2011 with global penetration of 87% of individuals, including 79% in the developing world <ref type="bibr">(International Telecommunication Union 2011)</ref>.</s></p><p xml:id="_wn3cGhY"><s xml:id="_8HQQGU7">Applying mobile phones in health care is a relatively young field of research with intervention studies being published just within the past decade.</s><s xml:id="_25y86qb">Text messaging (TM) interventions using short message service (SMS) have been most widely applied, while some investigators have tested interventions using a mobile phone application ('app') <ref type="bibr" target="#b26">(Meltzer et al. 2008</ref>).</s><s xml:id="_PyZnDr6">Previous reviews have described the breadth of research that has been conducted with mobile phones <ref type="bibr" target="#b16">(Haynes et al. 2008</ref><ref type="bibr" target="#b11">, Fjeldsoe et al. 2009</ref><ref type="bibr" target="#b20">, Krishna et al. 2009</ref><ref type="bibr" target="#b18">, Ingerski et al. 2011</ref><ref type="bibr">, Wei et al. 2011</ref><ref type="bibr" target="#b19">, de Jongh et al. 2012</ref><ref type="bibr" target="#b27">, Militello et al. 2012)</ref>.</s><s xml:id="_B2bFzmv">Recently, there has been Why is this research or review needed?</s></p><p xml:id="_kaNw8YY"><s xml:id="_gBH456j">• Medication non-adherence is a major global challenge and leads to increased morbidity and mortality.</s></p><p xml:id="_dNstePE"><s xml:id="_QUkmVAR">• Mobile phones are the most commonly used form of technology worldwide and have significant potential to promote health-related behavioural change and selfmanagement of acute and chronic disease.</s></p><p xml:id="_gERBmne"><s xml:id="_YrwgZyk">• Mobile phone interventions have been conducted to improve medication adherence with the recent advent of mobile health.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xkSQSeX">What are the key findings?</head><p xml:id="_ZmgJSZb"><s xml:id="_zdTy2TE">• A comprehensive systematic review found that 18 of 29 studies using text messaging improved medication adherence.</s></p><p xml:id="_SWaBHBg"><s xml:id="_qwGYZnW">• Negative studies tended to have more basic and repetitious content with a simple medication reminder, while positive studies delivered a variety of educational and motivational content with 'tailored' or 'personalized' SMS.</s></p><p xml:id="_WcAcFnr"><s xml:id="_cQfZqhH">• Text messaging interventions are feasible and acceptable with the majority of studies reporting high participant satisfaction (&gt;80%) in receiving text messages for health management.</s></p><p xml:id="_bwnQtjF"><s xml:id="_sJVa8r9">How should the findings be used to influence policy/ practice/research/education?</s></p><p xml:id="_dpswZma"><s xml:id="_FKJwm6j">• Nurses will be instrumental in developing strategies to include mobile health resources to promote medication adherence with patients and their caregivers in clinical practice and research settings.</s></p><p xml:id="_WthGxSr"><s xml:id="_qCgQCzW">• Further research is recommended to determine the efficacy of different mobile health approaches over time and to explore topics on patient acceptance, clinical outcomes, cost-effectiveness and theory supporting medication adherence behaviour.</s></p><p xml:id="_YpNA8Fh"><s xml:id="_QrarKNK">• Many opportunities exist in discovering the value and potential of mHealth initiatives to improve medication adherence for health promotion and chronic disease management.</s></p><p xml:id="_awwNatP"><s xml:id="_Fgfzr3M">a transition in mHealth, global health and funding agencies to move beyond the exploration phase of research (e.g.</s><s xml:id="_mKFnwgA">pilot studies, proof-of-concept) into an era of evidencebased interventions that are evaluated with the same rigour as other public health strategies <ref type="bibr" target="#b21">(Labrique et al. 2013)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cskpARN">The review Aims</head><p xml:id="_4DAVCx7"><s xml:id="_992bxj8">The major aim of this systematic review was to evaluate the efficacy of mobile phone interventions to improve medication adherence and to describe the characteristics of the interventions.</s><s xml:id="_pCmBVWj">Secondary aims were to explore acceptability and satisfaction of mobile phone interventions and to evaluate the selected studies in terms of study rigour, impact, cost and resource feasibility, generalizability and implications for nursing practice and research.</s><s xml:id="_aDMKpmx">The PICO (Population, Intervention, Comparison, Outcome) question for this research study was, 'Among those who take medications for prevention or treatment of acute/chronic illness, do mobile phone text messages improve medication adherence compared with those who do not receive text messages (when applicable)?'</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mDaYfdd">Design</head><p xml:id="_9QkbuDa"><s xml:id="_wG6TW9C">Guidelines from the Centre for Reviews and Dissemination (CRD) were followed to develop this quantitative systematic review without meta-analysis <ref type="bibr">(CRD 2008)</ref>.</s><s xml:id="_qRew85A">The core principles and methods from the CRD guidelines for conducting a systematic review of health interventions were followed <ref type="bibr">(CRD 2008)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kNujkbM">Search methods</head><p xml:id="_WMpfzdh"><s xml:id="_qhYqTHv">A comprehensive search was conducted to identify all studies that included the key review question of whether mobile phone interventions can support medication adherence in health promotion and disease management.</s><s xml:id="_abaaMzy">Studies from all countries published in English were included in the review.</s><s xml:id="_Hdx3ye3">To this end, a search was performed on PubMed, Web of Science, CINAHL, PsycInfo, Google Chrome and Cochrane databases to identify research publications related to this topic.</s><s xml:id="_qxfhyX9">In addition, bibliographies from related articles were reviewed to identify additional articles.</s><s xml:id="_TGkWja8">All full-text manuscripts from January 2002-January 2013 were identified by the first and second authors (LGP and JHE), including bibliographies of the chosen articles and related reviews.</s><s xml:id="_qw4f84f">Key terms were used alone and in combination with each other including 'mobile phone', 'cellular phone', 'text messages', 'text messaging', 'short message service', 'SMS', 'mobile phone application', 'medication' and 'medication adherence'.</s></p><p xml:id="_wDmHdak"><s xml:id="_Cx7JgJd">Inclusion criteria for this review were intervention studies that supported medication adherence via a mobile phone (i.e.</s><s xml:id="_VfvC8BN">TM, app) in health prevention or management of acute or chronic conditions.</s><s xml:id="_HTd6hGz">Medication use was measured by objective or subjective data in all studies to evaluate the efficacy of the interventions.</s><s xml:id="_WPQpEaY">Studies that used two modalities were included if the primary mode of intervention was mobile phones.</s><s xml:id="_duXqUFK">All patient populations and languages were considered.</s><s xml:id="_BbTf6M8">All study designs including randomized controlled trials (RCT), quasi-experimental studies and observational cohort studies were included in this review to capture the breadth of research that has been conducted as mHealth is a relatively new field.</s><s xml:id="_2yWyHE7">Pilot studies in mHealth were also included because they have been informative to understand the feasibility and acceptability of using mobile phones in health promotion and management.</s></p><p xml:id="_y5qt3xk"><s xml:id="_uWTPXsV">Studies were excluded if the interventions were predominantly conducted via Internet, email, traditional landline telephones or other electronic devices (two-way TM pagers, personal digital assistants, medication alarms) alone or in conjunction with mobile phones.</s><s xml:id="_kwjubEY">Studies that used co-interventions such as Internet-based communication along with TM were excluded.</s><s xml:id="_pkF94Bt">Studies that were based on calling patients on their mobile phones were also excluded as one of the key features of mHealth interventions is having less 'intrusive' methods of communicating with patients.</s><s xml:id="_SMbGVY3">Studies using mobile phones to communicate health data to healthcare providers (e.g.</s><s xml:id="_Ut8WKbx">glucose levels) were excluded if medication use was not explicitly addressed.</s><s xml:id="_ZSgBgMc">Last, more timely studies that were reported in journal abstracts or research conferences were excluded because they were not full-text articles and did not provide sufficient data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tmZzaXH">Search outcome</head><p xml:id="_raeqv3M"><s xml:id="_WH35p9j">A comprehensive electronic search produced 29 studies: 19 RCTs, two quasi-experimental studies, six pilot studies with no comparison group, one retrospective observational cohort study with matched control and one parallel twocohort study with randomization (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_Up9CCcD">Qualitative studies or other types of studies (case series, case reports, cross-sectional studies, case-control studies) were not found.</s><s xml:id="_a424RzP">All of the studies used TM as the primary intervention.</s><s xml:id="_gTfu5yC">No studies using mobile phone apps met the inclusion criteria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mGq4rfR">Quality appraisal</head><p xml:id="_e22juYW"><s xml:id="_TKeW5Xv">Quality assessment of the studies was conducted under the guidelines of the Cochrane Effective Practice and Organisation of Care Group (2012) (supplementary files).</s><s xml:id="_qADvXs4">Risk of bias was assessed among the diverse study designs that were included in this review.</s><s xml:id="_Pve2RR3">The assessment was completed by independent review of two researchers (LGP and KD).</s><s xml:id="_uHGqkME">The two reviewers discussed any items that were scored discordantly until agreement was reached.</s><s xml:id="_PRJc8Bm">There were significant methodological differences between the studies.</s><s xml:id="_Gm3MFTr">Narrative synthesis was performed as it was not possible to pool results with a meta-analysis.</s><s xml:id="_sEMWhYX">No studies were excluded on the basis of quality.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Sb2d2tM">Data abstraction</head><p xml:id="_3EMuE4H"><s xml:id="_wse8SQA">Data were abstracted from each eligible study including location, target condition, duration of study, design, sample characteristics, exposure of experimental and control groups, measures of medication adherence and results (Table <ref type="table" target="#tab_0">1</ref>).</s><s xml:id="_rbAc3JV">In addition, frequency, tracking (two-way messaging) and response rate, message content and satisfaction reports were recorded (Table <ref type="table" target="#tab_6">2</ref>).</s><s xml:id="_tWBmrT6">Supplemental data on methodologies were abstracted, such as sample size calculations, effect size calculations, attrition, cost-analyses and application of theory.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AepENYU">Synthesis</head><p xml:id="_th33bM9"><s xml:id="_AyfzBsf">The eligible studies differed substantially in the medical conditions, patient populations, interventions and measurement of medication adherence.</s><s xml:id="_7uNWG39">Therefore, each study was examined in the context of the medication adherence outcomes and patient-reported satisfaction.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_B57ercK">Results</head><p xml:id="_yfaF6Jy"><s xml:id="_zUZPtCp">Overall, 18 of the 29 studies were efficacious in improving medication adherence rates or biomarkers after receiving text messages (P &lt; 0Á05), while 11 studies reported no difference (Table <ref type="table" target="#tab_0">1</ref>).</s><s xml:id="_fJjnKvW">The interventions differed substantially across studies with a variety of message content and dosing (frequency, duration).</s><s xml:id="_hSFRcbc">Table <ref type="table" target="#tab_6">2</ref> describes the studies' tracking, message content and participants' satisfaction with the TM interventions.</s></p><p xml:id="_xepnyYw"><s xml:id="_NrdMJ3c">Noteworthy trends were observed between the positive and negative studies.</s><s xml:id="_zXZ7mSW">Among the negative studies, text messages tended to have more basic and repetitious content with a simple medication reminder.</s><s xml:id="_ueMaPV4">In contrast, positive studies delivered text messages with a variety of educational and motivational content that may have engaged more participants, thus leading to better outcomes.</s><s xml:id="_Kvxjwsj">In addition, positive effects on medication adherence occurred in all eight studies that applied 'tailored' or 'personalized' messages.</s><s xml:id="_YqQ4FVJ">Descriptions of interventions that authors used to describe their studies as offering 'tailored' or 'personalized' messages generally meant that the text messages used the participant's name, clinical condition or participant-chosen content.</s></p><p xml:id="_9A39AY3"><s xml:id="_tB96yb2">Among the 29 selected studies, the range of chronic disease processes that were treated varied from HIV/AIDS (7), diabetes (6), asthma (3), schizophrenia (2), hypertension (1), general chronic diseases (1), acne (1), atopic dermatitis (1), systematic lupus erythematosus (1) and immunosuppression after paediatric liver transplant (1).</s><s xml:id="_qyevuVp">One study      addressed antibiotic use for management of acute infections treated in the emergency department.</s><s xml:id="_Vb2umKm">Prevention studies included use of oral contraception (2), Vitamin C to prevent colds (1) and chemoprophylaxis to prevent malaria (1).</s><s xml:id="_cS55UXs">Among the RCTs, the sample sizes ranged from 16 to 962 participants.</s><s xml:id="_JjupKU6">Seventeen of the 29 studies (59%) had sample sizes of approximately 100 patients or less.</s><s xml:id="_DrfWjGp">The majority of studies included younger populations, although one focused specifically on older adults who were eligible for Medicare benefits (mean age of SMS cohort was 64Á8 SD 11Á9) <ref type="bibr" target="#b12">(Foreman et al. 2012)</ref>.</s><s xml:id="_QCcxgvX">The age range of participants was 11-78 years.</s><s xml:id="_QVJFhDc">Five studies included participants with a mean age over 50, which is a positive step forwards in establishing the generalizability of mobile phone interventions.</s><s xml:id="_byKPj5w">The majority of the studies included individuals from both genders.</s><s xml:id="_ryZVNXA">There were five studies that were gender-specific including three studies focused on women <ref type="bibr" target="#b17">(Hou et al. 2010</ref><ref type="bibr" target="#b4">, Castano et al. 2012</ref><ref type="bibr" target="#b8">, da Costa et al. 2012)</ref> and two studies on men <ref type="bibr" target="#b32">(Ollivier et al. 2009</ref><ref type="bibr" target="#b23">, Lewis et al. 2012)</ref>.</s></p><p xml:id="_DsvUVDj"><s xml:id="_b9AYP7D">The majority of investigators recruited a convenience sample from varied sites (e.g.</s><s xml:id="_8XYBdQj">clinics, hospitals, pharmacies and registries of prescription drug plans).</s><s xml:id="_bkUab5k">A few used advertisements in local newspapers and magazines as well as university and local websites.</s></p><p xml:id="_ggkuv6x"><s xml:id="_rukbrer">Thirteen studies sent messages that were strictly medication reminders.</s><s xml:id="_jUA9Fcq">The remaining studies used content other than medication reminders such as education, motivation, prescription-related information, tips on disease self-management, generic messages or a combination of messages that included medication reminders.</s><s xml:id="_fXRQ3aG">Several studies in this review used TM to enhance social support and remind patients to take their medication while communicating concern and providing assistance <ref type="bibr" target="#b13">(Franklin et al. 2003</ref><ref type="bibr" target="#b7">, Cocosila et al. 2009</ref><ref type="bibr" target="#b28">, Miloh et al. 2009</ref><ref type="bibr" target="#b22">, Lester et al. 2010</ref><ref type="bibr" target="#b38">, Pop-Eleches et al. 2011)</ref>.</s><s xml:id="_akE22Xa">One study on prevention of colds with Vitamin C among a young adult population sent interesting and light-hearted messages at random times from a virtual friend named 'Tim' <ref type="bibr" target="#b7">(Cocosila et al. 2009)</ref>.</s><s xml:id="_8eRTTt7">In an HIV intervention study, researchers in Kenya typically sent a weekly bulk message to 273 participants asking 'Mambo?' (How are you?) and research participants responded back either 'Sawa' (Doing well) or 'Shida' (I have a problem) <ref type="bibr" target="#b22">(Lester et al. 2010)</ref>.</s><s xml:id="_DqskR5c">Healthcare providers called participants who responded with the latter text, and at the end of the study, participants reported that they felt that someone cared about them <ref type="bibr" target="#b22">(Lester et al. 2010)</ref>.</s><s xml:id="_jk3a9vc">In contrast, other investigators in Kenya who targeted adults with HIV tested the effect of short vs. long messages and found no significant influence on adherence to antiretroviral medications after providing a longer message that offered social support <ref type="bibr" target="#b38">(Pop-Eleches et al. 2011)</ref>.</s></p><p xml:id="_sUMvX9A"><s xml:id="_2KZuETJ">Eight studies described their interventions as personalized or tailored.</s><s xml:id="_GHuDnGc">For example, one small pilot study with a younger HIV/AIDS population sent personalized messages that were developed by the participants at the beginning of the study (e.g.</s><s xml:id="_8NQZc3A">'Superman calling you,' 'Take it or die') <ref type="bibr" target="#b10">(Dowshen et al. 2012)</ref>.</s><s xml:id="_y5ZT46q">A visual analogue scale and a 4-day recall of medication administration showed significant changes in scores from baseline (74Á7 at baseline to 93Á1 at 24 weeks, P &lt; 0Á001), although the investigators could not document a significant change in CD4 cell count or viral load <ref type="bibr" target="#b10">(Dowshen et al. 2012)</ref>.</s></p><p xml:id="_mGV76zf"><s xml:id="_kCGyuDH">The content of messages using the Mobile Assessment and Treatment for Schizophrenia (MATS) programme was tailored in real-time and incorporated cognitive behavioural therapy <ref type="bibr" target="#b14">(Granholm et al. 2012)</ref>.</s><s xml:id="_c975Da9">The response to the first text message ('Did you take your meds today?') triggered a second level of questions that led to a final message with encouragement or advice on medication adherence <ref type="bibr" target="#b14">(Granholm et al. 2012)</ref>.</s><s xml:id="_qx9hHgE">In this study, medication adherence improved significantly over 12 weeks, but only for individuals who were living independently (P = 0Á018) <ref type="bibr" target="#b14">(Granholm et al. 2012)</ref>.</s></p><p xml:id="_fmSYGbX"><s xml:id="_TgEyz4B">While the majority of studies delivered messages once or twice daily, the frequency of delivery was optional <ref type="bibr" target="#b9">(Dick et al. 2011</ref><ref type="bibr">, Shetty et al. 2011</ref><ref type="bibr" target="#b12">, Foreman et al. 2012)</ref>.</s><s xml:id="_Mq68JN7">Only two studies tapered the frequency of messages through the duration of the intervention at 4 and 8 weeks <ref type="bibr" target="#b7">(Cocosila et al. 2009</ref><ref type="bibr" target="#b36">, Petrie et al. 2012)</ref>.</s><s xml:id="_pbUNY4D">The timing of delivery was commonly tailored to the participants' preferences or coincided with medication dosing.</s></p><p xml:id="_kkAeNkE"><s xml:id="_QjkPDXx">Frequency of TM was tailored real-time in a study with diabetic patients via an innovative Real Time Medication Monitoring (RTMM) system that used an electronic medication dispenser.</s><s xml:id="_UFqDfZ6">Customized reminders were sent only if the dispenser was not opened <ref type="bibr">(Vervloet et al. 2012)</ref>.</s><s xml:id="_qAQERKh">Overall, the TM group took significantly more doses within the agreed time period than the control group (57% vs. 43%, P = 0Á003); however, there were no differences in missed doses between the groups (15% vs. 19%, P = 0Á065) <ref type="bibr">(Vervloet et al. 2012)</ref>.</s></p><p xml:id="_KshaACz"><s xml:id="_9PWYvsw">The majority of studies delivered one-way messaging, while nine of the 28 studies had participants respond with two-way messaging.</s><s xml:id="_vcjkZMe">Two-way messaging allows for confirmation of text messages with a time-stamped response and is a means of engaging patients' involvement.</s><s xml:id="_hyeFUa6">The two-way response rates ranged from 35% to 86%.</s><s xml:id="_9V3tm8d">One study used 12 of 180 messages (0Á07%) as two-way for quality control purposes <ref type="bibr" target="#b4">(Castano et al. 2012)</ref>.</s><s xml:id="_tK93MGX">Along with daily medication reminders, other investigators offered weekly trivia questions that allowed participants to respond; however, the weekly two-way messaging response rate was only 35% <ref type="bibr" target="#b0">(Arora et al. 2012)</ref>.</s></p><p xml:id="_WejJdhU"><s xml:id="_Rf2CBj4">Accurate measurement of medication adherence is imperative when applying an intervention.</s><s xml:id="_JB7BStp">The discrepancy between self-reported and electronically monitored medication use was evident in some studies <ref type="bibr" target="#b15">(Hardy et al. 2011</ref><ref type="bibr" target="#b10">, Dowshen et al. 2012)</ref>.</s><s xml:id="_SyxCZQM">Self-report was the sole measure to report medication adherence in ten studies, while three studies used pharmacy data solely or in combination with other measurements <ref type="bibr" target="#b12">(Foreman et al. 2012</ref><ref type="bibr" target="#b25">, Mbuagbaw et al. 2012</ref><ref type="bibr">, Ting et al. 2012)</ref>.</s><s xml:id="_PDCwqmK">Other interventions ranged from exclusively using monitoring systems to reporting adherence through multiple measures (up to five).</s></p><p xml:id="_uczHJjb"><s xml:id="_r3v7eFe">In eight studies, adherence data were stored through electronic monitoring devices [Medication Event Monitoring System (MEMS), dose counts on inhalers] or real-time wireless communication to servers (SIMPill, RTMM system).</s><s xml:id="_bzStxSM">Other objective forms of medication adherence included manual pill counts, biomarkers and health outcomes (e.g.</s><s xml:id="_tXjGU3Q">haemoglobin A1C, viral loads, transplant rejection).</s><s xml:id="_tRHDsYd">Seventeen studies used biomarkers and health outcomes to assess medication adherence, while less than half of the (13) studies applied multiple methods to measure medication adherence.</s></p><p xml:id="_eutMnCp"><s xml:id="_Dy9buru">The majority of studies included an evaluation of participant satisfaction that is described in Table <ref type="table" target="#tab_6">2</ref>.</s><s xml:id="_7kzWp9e">A few studies had a brief statement on participant feedback, while most studies reported participants' satisfaction using a format of percentages or Likert scales.</s><s xml:id="_8emvrdE">Overall, the majority of studies reported high participant satisfaction (&gt;80%) in receiving text messages for health management.</s><s xml:id="_Qe7fUXT">The lowest satisfaction scores in reminding participants to take their medications included 64% of Brazilian women with HIV/AIDS <ref type="bibr" target="#b8">(da Costa et al. 2012)</ref>.</s><s xml:id="_Q2yP68p">In a study of clinic patients with atopic dermatitis, Boker et al. reported that 33% starting ignoring messages after 2 weeks and 26% found the messages to be 'annoying' <ref type="bibr">(2012)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qDkBZmH">Discussion</head><p xml:id="_GugYFGn"><s xml:id="_9pKKMnT">The majority of interventions (18 of 29) were efficacious in improving medication adherence.</s><s xml:id="_V637T26">These data are vital because non-adherence to medication regimens has remained a consistent and well-documented problem in health care.</s><s xml:id="_mgBzuBd">Mobile phones may be a useful adjunct to standard education and counselling about medications, thereby promoting the complex behaviour of medication adherence.</s><s xml:id="_PQFdhhq">The groundwork for using mobile phones to improve medication adherence has been explored through these studies, yet the possibilities of mHealth are abundant.</s><s xml:id="_cJxwFGx">The opportunities that exist with applying mobile phones in health interventions are exciting because mobile phones are so commonly used, widely accepted, easily accessible and affordable.</s><s xml:id="_6DazuUw">To inform future research on improving medication adherence from mobile phone interventions, the selected studies in this review will be evaluated in the following section in terms of study rigour, impact, cost and resource feasibility, generalizability and implications for nursing practice and research.</s></p><p xml:id="_5j4kRKd"><s xml:id="_9qkHvHv">More rigorous study designs and research methodologies will be important in future studies.</s><s xml:id="_dpda4AV">Reporting accurate sample size calculations, effect sizes, measurement and statistical analyses is essential to move the science of mHealth forwards.</s><s xml:id="_3KX5anV">Among the RCTs, 11 of the 20 studies included a sample size calculation.</s><s xml:id="_VyFRtbt">Some researchers reported that inaccurate and incomplete sample size calculations may have potentially affected their study results <ref type="bibr" target="#b34">(Ostojic et al. 2005</ref><ref type="bibr" target="#b7">, Cocosila et al. 2009)</ref>.</s><s xml:id="_2EtxZcw">Effect sizes were reported in only six studies.</s><s xml:id="_g8b9P7Q">Statistical significance was generally provided by P values, while confidence intervals were rarely reported, indicating a lack of reporting on statistical precision.</s><s xml:id="_HQtC3S3">A closer examination of the studies that did not reach statistical significance revealed several study design limitations that may have influenced the results.</s><s xml:id="_b5SE8MU">In addition to inaccurate sample size calculations and measurement issues, the use of additive or interactive effects may have compromised the results.</s><s xml:id="_wFHNZws">For example, investigators in a study of oral contraceptives realized that 88% of their patients used other co-interventions such as alternative alarm systems (e.g.</s><s xml:id="_hfV5Z6E">alarm clocks or mobile phone alarms) <ref type="bibr" target="#b17">(Hou et al. 2010)</ref>.</s></p><p xml:id="_cdwAXcc"><s xml:id="_35ZB5Tz">The application of quality assessment tools will identify potential biases and allow a systematic evaluation of the internal and external validity of the studies under review.</s><s xml:id="_dMgUkce">A risk of bias assessment of the current studies is presented in the supplementary tables.</s><s xml:id="_P3FTJFs">As expected, the non-RCT studies showed the highest risk of bias with the fewest criteria met.</s><s xml:id="_DRa46KU">Of the nine criteria, there was a range of 1-7 criteria met among the 29 studies.</s><s xml:id="_yyqcxPw">Five of the nine criteria were satisfied by the majority of studies; however, there were other criteria that were less frequently met or unclear (i.e.</s><s xml:id="_h3vBgHF">blinding, free of other bias given a non-RCT design).</s><s xml:id="_xcS7WdG">The quality of these studies is difficult to evaluate given the variety of rigour among the studies.</s><s xml:id="_e4QRB5r">For example, six pilot studies with no control group clearly had the highest risk of bias compared with other studies.</s><s xml:id="_PFUFYA3">The inclusion of pilot studies was still valuable because each study added to the growing evidence of the strengths and limitations of TM interventions to promote medication adherence in this young field of research.</s><s xml:id="_rCabXF7">Although the collective rigour is moderately weak, there is potential to build stronger confidence in future mHealth studies with more rigorous designs that account for potential biases as recommended in Cochrane EPOC (Cochrane Effective Practice &amp; Organisation of Care Group 2012).</s></p><p xml:id="_TyMhEwm"><s xml:id="_aE9xmM9">Regarding accurate measurement, a mixed methods approach with electronic devices, biomarkers and selfreport is an important component in strengthening rigour of a study protocol in data collection and corroborating data.</s><s xml:id="_Qp7KfhT">In addition, in studies with frequent follow-up visits, more sophisticated statistical models will be valuable to assess change over time without being influenced by missing data.</s><s xml:id="_3knBvQE">The spectrum of evaluation methods in mHealth research will need to include alternative study designs and methodologies to provide timely information in a rapidly evolving field <ref type="bibr" target="#b31">(Nilsen et al. 2012)</ref>.</s></p><p xml:id="_HYCpVs5"><s xml:id="_uJbyAua">Among the studies, the highest attrition rate was 41% at a mean of 4 months in a year-long study of paediatric liver transplant patients <ref type="bibr" target="#b28">(Miloh et al. 2009)</ref>.</s><s xml:id="_TKeNkn2">Although there were no reported risk factor differences in patients who dropped out, the positive results of receiving text messages to improve adherence to immunosuppressant therapy among the experimental group may have been influenced by the higher adherence characteristics of the remaining patients overall <ref type="bibr" target="#b28">(Miloh et al. 2009)</ref>.</s><s xml:id="_ZpVT8mJ">Both the mean and median rates of attrition in all these studies were 15%.</s></p><p xml:id="_4zsTrzz"><s xml:id="_dhBc9UQ">The long-term impact of mHealth interventions is needed to document the efficacy and sustainability of these interventions on chronic disease management.</s><s xml:id="_7MjJ2uK">The longest study period was 14 months, with the mean and median study durations being 21 and 16 weeks respectively.</s><s xml:id="_6wwEphQ">A major barrier in using mobile technology may be deterioration of interest as the novelty of the messages decreases over time.</s><s xml:id="_7mkXgNs">Factors that maintain engagement of participants remain unknown and serve as important gaps in research.</s><s xml:id="_D7qxDUA">The content of text messages may be a determining factor in patients' continued interest and persistence in using mobile phones to improve medication adherence.</s><s xml:id="_6sqf4AB">Messages varied widely in content among the studies, with some interventions giving the same daily reminder to take medications and other interventions using a variety of messages that varied in topic.</s><s xml:id="_XYkj4qn">Although more personable messages might appear to better engage users, the impact of such methods requires further study <ref type="bibr" target="#b28">(Miloh et al. 2009</ref><ref type="bibr" target="#b38">, Pop-Eleches et al. 2011)</ref>.</s><s xml:id="_UdjByRR">Tailoring messages with personalized content, building on responses from participants and delivering messages in different languages may help to make a more customized programme that engages participants.</s></p><p xml:id="_zuJsAek"><s xml:id="_BAZUReR">Future studies that focus on the impact of specific TM protocols and are age, gender and culture specific will develop our knowledge about culturally appropriate interventions <ref type="bibr">(Strandbygaard et al. 2010)</ref>.</s><s xml:id="_fWVYjpt">Research should be designed and interpreted in culture-specific contexts.</s><s xml:id="_fKP8Sgq">For example, interventions that are targeted at health conditions associated with negative stigma such as HIV require consideration in maintaining confidentiality.</s><s xml:id="_W7tbgE8">In the study in Cameroon, a high proportion of participants disclosed their HIV status to their families during the course of the study <ref type="bibr" target="#b25">(Mbuagbaw et al. 2012)</ref>.</s><s xml:id="_XkJDCyF">In this study, 35% did not want to continue receiving messages at the end of the trial period, which might indicate the participants' sensitivity in receiving messages associated with their health status <ref type="bibr" target="#b25">(Mbuagbaw et al. 2012)</ref>.</s></p><p xml:id="_7bsAYaF"><s xml:id="_qH5tpXT">Importantly, clinical outcomes that are tracked over time to determine efficacy and sustainability of TM interventions and health-related apps are fundamental to mHealth intervention design.</s><s xml:id="_75BzcYh">The majority of research studies reviewed here demonstrated feasibility in supporting medication adherence as well as high acceptability and satisfaction among participants.</s><s xml:id="_8pMxnnY">Long-term studies are needed to provide and guide future intervention design, so that mHealth can be fully integrated into daily life.</s></p><p xml:id="_FGj47WJ"><s xml:id="_UBsW2rV">In future studies, the cost of implementing a mobile phone intervention needs to be addressed from the providers' and participants' perspectives.</s><s xml:id="_YVVRFt2">Implementing cost-effective programmes for long-term participation will continue to be an important factor in achieving positive outcomes.</s><s xml:id="_yKf5nb7">Among the studies reviewed, some participants reported concerns about costs if they continued with the TM programme <ref type="bibr" target="#b15">(Hardy et al. 2011)</ref>.</s><s xml:id="_FQR6WQv">Providing options such as limiting two-way messaging to reduce costs for participants who have limited TM plans may be a consideration in future studies.</s><s xml:id="_eftYhZv">Only five studies reported a cost-analysis of their medication adherence interventions.</s><s xml:id="_XhabZfZ">Cost-analyses will provide important information for policy makers and global funders, particularly in HIV research because reducing viral replication through antiretroviral therapy can decrease transmission of HIV to new partners <ref type="bibr" target="#b22">(Lester et al. 2010)</ref>.</s><s xml:id="_qaTPEMQ">Use of mobile phones may offer a major prevention strategy in regions where HIV is endemic and other resources are limited.</s><s xml:id="_T7MWw87">Another cost-analysis derived by a national pharmacy benefit manager found only a slight increase in pharmacy-related costs for the group who received text messages compared with the matched control group, although the differences were not statistically significant <ref type="bibr" target="#b12">(Foreman et al. 2012)</ref>.</s><s xml:id="_FEER9SR">The total healthcare costs for these groups were not analysed but would be beneficial when determining the overall cost benefit of the intervention.</s><s xml:id="_EvWg8UM">Consideration of reimbursement models for medication adherence and mHealth interventions is also needed <ref type="bibr" target="#b2">(Bosworth et al. 2011)</ref>.</s></p><p xml:id="_2ec2AxD"><s xml:id="_tm2VQah">In terms of generalizability, it is difficult to generalize the positive findings of the studies to other populations given the differences in study design, group characteristics, comorbidities and intensity in managing medical conditions.</s><s xml:id="_v8fTYkw">Caution is necessary when extrapolating results from different patient populations and conditions such as applying findings from teenagers with diabetes administering insulin <ref type="bibr" target="#b13">(Franklin et al. 2003)</ref> to older adults who are managing multiple chronic diseases with several different classes of medications <ref type="bibr" target="#b12">(Foreman et al. 2012)</ref>.</s><s xml:id="_Dzh9thu">Likewise, caution is necessary when extrapolating results with chronic disease populations to healthy individuals who are practising primary prevention behaviours such as Vitamin C use <ref type="bibr" target="#b7">(Cocosila et al. 2009)</ref>.</s><s xml:id="_wYqRmBE">More studies in areas of health promotion as opposed to chronic disease management are needed as a literature search produced a few studies to date.</s><s xml:id="_UdBWCKt">Regarding the generalizability of the findings to older adults, several studies emerged from this review that successfully included older adults in using mobile phones for improved medication adherence.</s><s xml:id="_RZEYfKA">Mobile health resources may be offered as a supplement to the care of older adults, family members and caregivers as patients live with chronic diseases.</s><s xml:id="_5wAJvyD">Although penetration of mobile phones among older adults may be challenging due to the lack of familiarity with current technology, this is likely to change among individuals who regularly use TM or apps age <ref type="bibr" target="#b36">(Petrie et al. 2012)</ref>.</s></p><p xml:id="_BbYWnYg"><s xml:id="_X5DvCd3">Sensitivity to literacy and languages will support mobile phone interventions that reach global populations and increase generalizability.</s><s xml:id="_wy2CBTM">Four studies in this review allowed participants to choose their language preference (Pop- <ref type="bibr" target="#b38">Eleches et al. 2011</ref><ref type="bibr" target="#b0">, Arora et al. 2012</ref><ref type="bibr" target="#b4">, Castano et al. 2012</ref><ref type="bibr" target="#b25">, Mbuagbaw et al. 2012)</ref>.</s><s xml:id="_h4rRm3J">The global reach of mHealth research is demonstrated in this review with 14 countries being represented, although 13 of the 29 studies were conducted in the USA.</s><s xml:id="_UnVQwQM">Valuable insight into mobile phone interventions in countries with few resources was provided by studies conducted in Kenya, Cameroon and India.</s><s xml:id="_uTEX36b">Due to the ubiquitous nature of mobile phones across diverse populations, the modality of mobile technology may be generalizable across many more cultures.</s></p><p xml:id="_Z8emGAQ"><s xml:id="_JCGKnPv">This study offers several implications for nursing practice and research.</s><s xml:id="_Tk9nvW9">Patients can be empowered to adhere to medication prescriptions through nursing practice.</s><s xml:id="_szxWt8y">Prescription counselling often comes from nurses in hospital, outpatient or community settings.</s><s xml:id="_Suj6MxJ">Developing strategies with patients and their caregivers to promote medication adherence may be key to successful self-management.</s><s xml:id="_m4Nvrhr">Nurses can play an important role in keeping current with the growing number of available mHealth and telemedicine resources for patients.</s><s xml:id="_wzUXRHX">Nurses are encouraged to embrace an innovative and creative spirit to consider the potential of mobile technology to be a cost-effective and efficacious tool to improve medication adherence.</s></p><p xml:id="_bxyJzTz"><s xml:id="_44ESPaS">Many opportunities remain in building mHealth science.</s><s xml:id="_VSxz5Ft">Future research may assess the impact on medication adherence and user fatigue from various message contents, frequency of reminders and text responses <ref type="bibr" target="#b15">(Hardy et al. 2011)</ref>.</s><s xml:id="_Hz3xVdv">Moreover, integration of real-time feedback on disease management will be instrumental in designing future interventions <ref type="bibr" target="#b14">(Granholm et al. 2012</ref><ref type="bibr">, Vervloet et al. 2012)</ref>.</s><s xml:id="_hHUgdkt">Nurses can make a significant contribution to understanding the potential of mHealth by applying mixed methods study designs with quantitative and qualitative research as well as applying a theoretical framework to mHealth research related to medication adherence.</s></p><p xml:id="_SSfPHkQ"><s xml:id="_edRyFu9">In this review, only five of 29 studies used theory to guide their research.</s><s xml:id="_dUf4Umt">The theories were Transtheoretical Model <ref type="bibr" target="#b4">(Castano et al. 2012)</ref>, Social Cognitive Theory <ref type="bibr" target="#b13">(Franklin et al. 2003)</ref>, Health Belief Model of Behavior Change <ref type="bibr" target="#b25">(Mbuagbaw et al. 2012)</ref>, Behavioral Learning Theory <ref type="bibr" target="#b29">(Montes et al. 2012)</ref> and Theory of Planned Behavior <ref type="bibr">(Suffoletto et al. 2012</ref>).</s><s xml:id="_6BbHfus">It will be important for nurse scientists who design future studies to use a theoretical basis to explain the relationship between study variables.</s><s xml:id="_R4B6eWy">Other health behavioural theories may be developed that take into account the time-intensive, interactive and adaptive nature of mHealth interventions that demand more intra-individual dynamic regulatory processes <ref type="bibr" target="#b39">(Riley et al. 2011)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_k7vGZgW">Conclusion</head><p xml:id="_PQvAY83"><s xml:id="_NubEBYh">The potential impact of mobile technology in disease prevention and management may be substantial.</s><s xml:id="_uVxYzHP">Research identified in this systematic review has introduced the use of mobile phones to support medication adherence among different patient populations.</s><s xml:id="_fzxdcSq">Future research is required to substantiate these early findings and to provide data on long-term follow-up in a variety of patient populations.</s><s xml:id="_5qUg3rA">Applying appropriate statistical approaches combined with rigorous theory-based interventions may provide important insights into the efficacy and acceptance of mHealth by patients related to medication use and the factors that mediate its efficacy.</s><s xml:id="_fJUmVcv">Future studies are required to determine the efficacy of different approaches over time and to explore topics such as patient acceptance, clinical outcomes, cost-effectiveness and theory supporting medication adherence behaviour.</s></p><p xml:id="_w7rPvDh"><s xml:id="_Jenf9rj">The next decade of research with mobile phones will likely evolve into applying more smartphone apps in place of TM interventions.</s><s xml:id="_3scdSpn">The efficacy of mobile phone apps vs.</s></p><p xml:id="_BkfbbkW"><s xml:id="_FwEJak2">TM has yet to be explored in research.</s><s xml:id="_rqcWBbt">As the number of smartphone users continues to grow with 58% of Americans owning a smartphone in 2014 (Pew Research Center 2014), interventions that apply apps as opposed to TM will inform us about the full potential of mHealth to support medication adherence and disease management.</s><s xml:id="_YB5QMdZ">The features that are available from smartphones will likely engage users by allowing more interaction and increased variability.</s></p><p xml:id="_2843nGf"><s xml:id="_uWFdCW8">Mobile health will continue to enhance clinical practice and allow for easily accessible and remote solutions, especially for patients with chronic diseases requiring lifelong medication adherence for optimal outcomes.</s><s xml:id="_uKqhjnX">The real possibilities of mHealth in promoting medication adherence await further research and will continue to take shape as the results of pilot studies and rigorous intervention trials continue to inform us in this promising field.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p xml:id="_kBeRKkt"><s xml:id="_wMZYbMw">Figure 1 Flow chart of study selection process.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p xml:id="_8f9YvjP"><s xml:id="_NGpTrNk">Studies on mobile phones and medication adherence.</s></p></div></figDesc><table><row><cell>Results (med</cell><cell>adherence and/</cell><cell>or biomarker)</cell><cell>Significant improvement on MMAS score</cell><cell>(3Á5-4Á75).</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>No significant difference in mean adherence</cell><cell>rates between EG and CG (33Á9% vs. 36Á5%</cell><cell>respectively; P = 0Á5). Self-reported adherence</cell><cell>(responses received) for EG was 74Á4%.</cell><cell>Both groups had similar clinical improvement</cell><cell>of acne.</cell><cell>Significant difference in mean adherence rates</cell><cell>between EG and CG (75% vs. 54% respectively;</cell><cell>P = 0Á003) if follow-up occurred while</cell><cell>intervention was ongoing. Adherence was</cell><cell>not different between groups after 187 days,</cell><cell>5-8 months or more.</cell><cell>No significant difference in missed pills during</cell><cell>last week of trial between EG and CG</cell><cell>(2Á5 AE 1Á5 vs. 3Á3 AE 2Á2 respectively). Both</cell><cell>groups increased Vitamin C adherence:</cell><cell>1Á3-4Á5 (246%) for EG, 1Á6-3Á7 (131%) for CG.</cell><cell>No significant differences in adherence between</cell><cell>EG and CG. Self-report 100% vs. 84Á62%</cell><cell>respectively; P = 0Á24. Pill counts 50% vs.</cell><cell>38Á46% respectively; P = 0Á60. MEMS 75% vs.</cell><cell>46Á15%, respectively; P = 0Á19.</cell><cell>Significant decrease in number of reported</cell><cell>missed med doses from a mean of 1Á9 per week</cell><cell>at baseline to 0Á6 during the study period</cell><cell>(P = 0Á003) and 0Á8 at 1 month follow-up</cell><cell>(P &lt; 0Á001).</cell></row><row><cell></cell><cell>Measures of</cell><cell>med adherence</cell><cell>Morisky Medication</cell><cell>Adherence Scale</cell><cell>(MMAS)</cell><cell></cell><cell></cell><cell></cell><cell>Med tube with MEMS,</cell><cell>clinical evaluation</cell><cell>of acne</cell><cell></cell><cell></cell><cell></cell><cell>Self-report on continued</cell><cell>OCP use, missed pills,</cell><cell>interruptions in</cell><cell>med use, use at last</cell><cell>intercourse</cell><cell></cell><cell>Self-reported pill counts</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Self-reported adherence,</cell><cell>pill counting and MEMS</cell><cell></cell><cell></cell><cell></cell><cell>Self-report on number</cell><cell>of med doses missed in</cell><cell>periods before, during</cell><cell>and 1 month</cell></row><row><cell>Exposure of</cell><cell>experimental and</cell><cell>control groups</cell><cell>SMS with health</cell><cell>messages and triggers</cell><cell>to promote knowledge,</cell><cell>healthy eating, exercise,</cell><cell>self-efficacy and med</cell><cell>adherence</cell><cell>EG: SMS on med</cell><cell>reminders for 2</cell><cell>different gels for</cell><cell>acne treatment</cell><cell>CG: No SMS</cell><cell></cell><cell>EG: SMS with</cell><cell>educational content</cell><cell>CG: Routine care</cell><cell></cell><cell></cell><cell></cell><cell>EG: SMS med reminders</cell><cell>CG: No SMS</cell><cell></cell><cell></cell><cell></cell><cell>EC: SMS general</cell><cell>health message</cell><cell>CG: No SMS</cell><cell></cell><cell></cell><cell>'Personalized' SMS</cell><cell>on med, blood sugar,</cell><cell>foot care, appointment,</cell><cell>or administrative</cell></row><row><cell>Design, sample size,</cell><cell>mean age (SD or</cell><cell>range), gender</cell><cell>Proof-of-concept;</cell><cell>N = 23;</cell><cell>45Á4 AE 7Á5;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell>RCT;</cell><cell>N = 40;</cell><cell>22Á7 AE 5Á7;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell>RCT;</cell><cell>N = 962;</cell><cell>EG 20Á8 AE 2Á5</cell><cell>CG 20Á4 AE 2Á7; Female</cell><cell></cell><cell></cell><cell>RCT;</cell><cell>N = 102;</cell><cell>23Á8 AE 7;</cell><cell>Male &amp; female</cell><cell></cell><cell>RCT;</cell><cell>N = 21;</cell><cell>34Á6 AE 6Á9; Female</cell><cell></cell><cell></cell><cell>Feasibility and</cell><cell>usability pilot;</cell><cell>N = 18;</cell><cell>55 (38-72);</cell><cell>Male &amp; female</cell></row><row><cell>Target condition</cell><cell>and duration of</cell><cell>study (months)</cell><cell>Diabetes</cell><cell>3 weeks</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Acne</cell><cell>12 weeks</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Oral contraceptive</cell><cell>pills</cell><cell>6 months</cell><cell></cell><cell></cell><cell></cell><cell>Prevention of colds:</cell><cell>Vitamin C use</cell><cell>1 month</cell><cell></cell><cell></cell><cell>HIV/AIDS</cell><cell>4 months</cell><cell></cell><cell></cell><cell></cell><cell>Diabetes</cell><cell>1 month</cell></row><row><cell></cell><cell>First author,</cell><cell>year, Country</cell><cell>Arora (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Boker (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Castano (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Cocosila (2009)</cell><cell>Canada</cell><cell></cell><cell></cell><cell></cell><cell>da Costa (2012)</cell><cell>Brazil</cell><cell></cell><cell></cell><cell></cell><cell>Dick (2011)</cell><cell>US</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 (</head><label>1</label><figDesc><div><p xml:id="_BXjp9Mj"><s xml:id="_Stm8kFh">Continued).</s></p></div></figDesc><table><row><cell>Results (med</cell><cell>adherence and/</cell><cell>or biomarker)</cell><cell>Significant increase in VAS at 12 and 24 weeks</cell><cell>(baseline: 74Á7; week 12: 93Á3, P &lt; 0Á001; week</cell><cell>24: 93Á1, P &lt; 0Á001). Significant improvement</cell><cell>in ACTG questionnaire (baseline: 2Á33; week</cell><cell>12: 3Á24, P = 0Á002; week 24: 3Á19, P = 0Á005).</cell><cell>No significant difference in CD4 cell count or</cell><cell>viral load between baseline and 12-or 24-week</cell><cell>follow-up. Small-to-moderate effect size</cell><cell>(Cohen's d = À0Á51 to 0Á22).</cell><cell>Significant overall mean PDC higher for</cell><cell>EG compared with CG (0Á85 vs. 0Á77</cell><cell>respectively; P &lt; 0Á001).</cell><cell>Significant overall mean PDC change higher for</cell><cell>EG compared with CG (0Á01 vs. À0Á07</cell><cell>respectively; P &lt; 0Á001).</cell><cell></cell><cell>Significant difference in VAS between</cell><cell>conventional insulin therapy (CIT) patients and</cell><cell>CIT with Sweet Talk (P = 0Á04). No difference</cell><cell>between CIT with Sweet Talk and intensive</cell><cell>insulin therapy patients (IIT) (P = 0Á90).</cell><cell></cell><cell>Significant improvement in adherence, but only</cell><cell>for individuals who were living independently.</cell><cell></cell><cell></cell><cell></cell><cell>Significant differences in mean adherence between</cell><cell>groups when measured by MEMS (mean</cell><cell>difference: 33Á4 AE 9Á1, P = 0Á002) and</cell><cell>composite score (27Á1 AE 9Á2, P = 0Á01). No</cell><cell>significant difference by pill count (13Á7 AE 9Á1,</cell><cell>P = 0Á15) or self-report (20Á2 AE 10Á3, P = 0Á07).</cell><cell>No significant difference in missed OCP per cycle</cell><cell>AE 3Á0 vs. 4Á6 AE 3Á5, between EG and CG (4Á9</cell><cell>respectively; P = 0Á60).</cell></row><row><cell></cell><cell>Measures of</cell><cell>med adherence</cell><cell>VAS and AIDS Clinical</cell><cell>Trial Group (ACTG)</cell><cell>questionnaire 4-day</cell><cell>recall</cell><cell>Viral load and CD4</cell><cell>cell count at baseline,</cell><cell>12 and 24 weeks</cell><cell></cell><cell></cell><cell>Proportion of days</cell><cell>covered (PDC)</cell><cell>Change in PDC from</cell><cell>baseline to</cell><cell>postintervention</cell><cell></cell><cell></cell><cell>VAS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Self-report</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Self-report (7-day recall),</cell><cell>pill count, MEMS and</cell><cell>composite adherence</cell><cell>score (combining</cell><cell>MEMS, pill count</cell><cell>and self-report)</cell><cell>Electronic monitoring</cell><cell>device to store OCP</cell><cell>(SIMPill) and paper</cell><cell>diary</cell></row><row><cell>Exposure of</cell><cell>experimental and</cell><cell>control groups</cell><cell>'Personalized' SMS</cell><cell>as med reminder</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>EG: choice of SMS on</cell><cell>refill, renewals, transfer,</cell><cell>order shipment, general</cell><cell>or specific med reminder</cell><cell>CG: matched 1:1 on med</cell><cell>class, then propensity</cell><cell>matching score</cell><cell>EG: 'Personalized'</cell><cell>motivational SMS with</cell><cell>'Sweet Talk'</cell><cell>CG: Standard of care</cell><cell></cell><cell></cell><cell>'Personalized' SMS to</cell><cell>target med adherence,</cell><cell>socialization or</cell><cell>auditory hallucinations</cell><cell></cell><cell>SMS group:</cell><cell>'Personalized' SMS</cell><cell>with med reminders</cell><cell>Beeper group:</cell><cell>med reminders</cell><cell>EG: SMS med reminders</cell><cell>CG: No SMS</cell></row><row><cell>Design, sample size,</cell><cell>mean age (SD or</cell><cell>range), gender</cell><cell>Pilot, pre-post design;</cell><cell>N = 25;</cell><cell>23 AE 3Á1;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Retrospective</cell><cell>observational</cell><cell>cohort analysis;</cell><cell>N = 580;</cell><cell>EG 64Á8 AE 11Á9</cell><cell>CG 63Á7 AE 13Á7;</cell><cell>Male &amp; female</cell><cell>RCT;</cell><cell>N = 92;</cell><cell>CIT 12Á7 (10Á5-14Á8)</cell><cell>CIT + SMS 14Á1 (11Á7-15Á6)</cell><cell>IIT + SMS 12Á6 (11Á2-15Á4);</cell><cell>Male &amp; female</cell><cell>Feasibility and</cell><cell>usability pilot;</cell><cell>N = 55;</cell><cell>48Á7 AE 9Á1;</cell><cell>Male &amp; female</cell><cell>Parallel group RCT;</cell><cell>N = 25;</cell><cell>42Á7 AE 6Á5;</cell><cell>Male &amp; female</cell><cell>RCT;</cell><cell>N = 82;</cell><cell>EG: 22 (18-31)</cell><cell>CG: 22 (18-30);</cell><cell>Female</cell></row><row><cell>Target condition</cell><cell>and duration of</cell><cell>study (months)</cell><cell>HIV/AIDS</cell><cell>24 weeks</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Chronic oral</cell><cell>med(s)</cell><cell>8 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Diabetes</cell><cell>12 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Schizophrenia or</cell><cell>schizoaffective</cell><cell>disorder</cell><cell>12 weeks</cell><cell></cell><cell>HIV/AIDS</cell><cell>6 weeks</cell><cell></cell><cell></cell><cell>Oral contraceptive</cell><cell>pills</cell><cell>3 months</cell></row><row><cell></cell><cell>First author,</cell><cell>year, Country</cell><cell>Dowshen (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Foreman (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Franklin (2003)</cell><cell>Scotland</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Granholm</cell><cell>(2012) US</cell><cell></cell><cell></cell><cell></cell><cell>Hardy (2011)</cell><cell>US</cell><cell></cell><cell></cell><cell>Hou (2010)</cell><cell>US</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 (</head><label>1</label><figDesc><div><p xml:id="_jkzSMBS"><s xml:id="_rWdFKSX">Continued).</s></p></div></figDesc><table><row><cell>Results (med</cell><cell>adherence and/</cell><cell>or biomarker)</cell><cell>Significant difference in adherence rates between</cell><cell>EG and CG (RR for non-adherence 0Á81, 95%</cell><cell>CI 0Á69-0Á94; P = 0Á006). Significant difference</cell><cell>in suppressed viral loads between groups</cell><cell>(RR for virological failure 0Á85, 95%</cell><cell>CI 0Á72-0Á99; P = 0Á04).</cell><cell>Significant difference in number of missed med</cell><cell>days for participants from baseline to follow-up</cell><cell>(1Á90 AE 1Á22 vs. 0Á94 AE 1Á09, Cohen's d = 0Á83;</cell><cell>t(16) = 2Á22, P = 0Á04). Significant reduction in</cell><cell>viral load from baseline to follow-up (P = 0Á01;</cell><cell>Cohen's d = À0Á40) and CD4 counts (P = 0Á04;</cell><cell>Cohen's d = 0Á21).</cell><cell>No significant difference in mean percentage of</cell><cell>adherence between EG and CG</cell><cell>(91Á9% AE 11Á5% vs. 88Á1% AE 20Á8%,</cell><cell>respectively; P = NS). No significant difference</cell><cell>in blood pressure control between EG and CG</cell><cell>(64Á7% vs. 51Á5% respectively; P = NS).</cell><cell>No significant difference in VAS between groups</cell><cell>(RR 1Á06, 95% CI 0Á89-1Á29; P = 0Á54) or</cell><cell>self-reported missed doses (RR 1Á01, 95%</cell><cell>CI 0Á87-1Á16; P = 0Á99). No difference in PRD</cell><cell>between groups (mean difference 0Á1, 95% CI</cell><cell>0Á23-0Á43; P = 0Á62). EG achieved adherence of</cell><cell>90% at 6 months (RR 1Á14, 95%</cell><cell>CI 1Á01-1Á29; P = 0Á03).</cell><cell>Significant decrease in tacrolimus level SD before</cell><cell>compared with during the study (3Á46-1Á37 mcg/L</cell><cell>(P &lt; 0Á005). Significant reduction in acute cellular</cell><cell>rejection before compared with during the</cell><cell>study (12-2, v 2 = 5Á08; P = 0Á02).</cell></row><row><cell></cell><cell>Measures of</cell><cell>med adherence</cell><cell>Self-reported adherence</cell><cell>and plasma HIV-1 viral</cell><cell>RNA load suppression</cell><cell></cell><cell></cell><cell></cell><cell>Self-report of missed</cell><cell>doses and clinical</cell><cell>outcomes (viral load</cell><cell>and CD4 count)</cell><cell></cell><cell></cell><cell></cell><cell>Pill counts and blood</cell><cell>pressure recordings</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>VAS, self-report,</cell><cell>pharmacy refill</cell><cell>data (PRD)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Mean tacrolimus SD,</cell><cell>clinical outcomes</cell><cell>(rejection)</cell><cell></cell><cell></cell></row><row><cell>Exposure of</cell><cell>experimental and</cell><cell>control groups</cell><cell>EG: SMS med reminders</cell><cell>CG: Standard</cell><cell>of care</cell><cell></cell><cell></cell><cell></cell><cell>'Tailored' frequency</cell><cell>of SMS med</cell><cell>reminders depending</cell><cell>on weekly assessment</cell><cell>of adherence</cell><cell></cell><cell></cell><cell>EG: SMS med</cell><cell>reminders and</cell><cell>health info</cell><cell>CG: Standard of</cell><cell>care</cell><cell></cell><cell>EG: SMS with</cell><cell>motivational and</cell><cell>reminder components</cell><cell>CG: Standard of care</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>SMS med reminders</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Design, sample size,</cell><cell>mean age (SD or</cell><cell>range), gender</cell><cell>RCT;</cell><cell>N = 538;</cell><cell>36Á7 AE 8Á5;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell>Proof-of-concept;</cell><cell>N = 52;</cell><cell>38 (25 to over 60);</cell><cell>Male</cell><cell></cell><cell></cell><cell></cell><cell>RCT;</cell><cell>N = 67;</cell><cell>57 AE 10Á6;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell>RCT;</cell><cell>N = 200;</cell><cell>EG: 41Á3 AE 10Á1</cell><cell>CG: 39Á0 AE 10Á0;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell></cell><cell>Quasi-experimental;</cell><cell>N = 41;</cell><cell>Median age 15 (2-27);</cell><cell>Male &amp; female</cell><cell></cell></row><row><cell>Target condition</cell><cell>and duration of</cell><cell>study (months)</cell><cell>HIV</cell><cell>12 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>HIV</cell><cell>3 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Hypertension</cell><cell>6 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>HIV</cell><cell>6 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Immunosuppression</cell><cell>posttransplant</cell><cell>13 AE 1Á5 months</cell><cell></cell><cell></cell></row><row><cell></cell><cell>First author,</cell><cell>year, Country</cell><cell>Lester (2010)</cell><cell>Kenya</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Lewis (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Marquez</cell><cell>Contreras (2004)</cell><cell>Spain</cell><cell></cell><cell></cell><cell></cell><cell>Mbuagbaw</cell><cell>(2012)</cell><cell>Cameroon</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Miloh (2009)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 1 (</head><label>1</label><figDesc><div><p xml:id="_2PSkzT4"><s xml:id="_WqhmrG5">Continued).</s></p></div></figDesc><table><row><cell>Results (med</cell><cell>adherence and/</cell><cell>or biomarker)</cell><cell>Significant change in MAQ total score between</cell><cell>EG and CG (25% vs. 17Á5% respectively).</cell><cell>Mean changes in MAQ total score from baseline</cell><cell>to month 3 were À1Á0 (95% CI À1Á02 to À0Á98)</cell><cell>for EG and À0Á7 (95% CI À0Á72 to À0Á68) for</cell><cell>CG (P = 0Á02).</cell><cell>Significant change remained 3 months after SMS</cell><cell>with mean changes in MAQ total score À1Á1</cell><cell>(95% CI À1Á12 to À1Á08) for EG and À0Á8 (95%</cell><cell>CI À0Á81 to À0Á78) for CG (P = 0Á04).</cell><cell>No significant difference in med adherence between</cell><cell>groups. Decreased adherence rate in both groups</cell><cell>(EG 94Á6% to 67Á6% and CG 95Á2% to 65Á8%).</cell><cell></cell><cell>No significant difference in daily use of inhaled</cell><cell>med between groups (steroids, P = 0Á57; beta</cell><cell>2-agonists, P = 0Á38). EG used 20% higher doses</cell><cell>compared with CG. Significant increase in</cell><cell>FEV1% predicted in EG (P = 0Á01) compared</cell><cell>with CG (P = 0Á50). No change in mean FEV1 or</cell><cell>forced vital capacity. PEF variability significantly</cell><cell>different between groups (P = 0Á049), although</cell><cell>not absolute PEF. Significantly higher symptom</cell><cell>scores in CG for cough (P = 0Á05) and night</cell><cell>symptoms (P = 0Á05).</cell><cell>Significant improvement in mean number of</cell><cell>days/week of adherence from pre-to</cell><cell>postintervention among 72% of participants</cell><cell>(3Á8 AE 2Á4 vs. 6Á0 AE 1Á7 respectively; P &lt; 0Á001).</cell><cell>Significant difference in mean adherence across all</cell><cell>time points (6, 12 and 18 weeks; 6 and 9 months)</cell><cell>between EG and CG (57Á8% AE 27Á1 vs.</cell><cell>43Á2% AE 26; P = 0Á003).</cell><cell>Significant difference in proportions of mean</cell><cell>adherence of 80% or above between EG and CG</cell><cell>(25Á9% vs. 15Á3%; P = 0Á03).</cell></row><row><cell></cell><cell>Measures of</cell><cell>med adherence</cell><cell>Morisky Green</cell><cell>Adherence</cell><cell>Questionnaire (MAQ)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>MEMS</cell><cell></cell><cell></cell><cell></cell><cell>Use of asthma med;</cell><cell>pulmonary function test</cell><cell>(FEV1% and mean FEV1);</cell><cell>daily symptoms; home</cell><cell>PEF (peak expiratory flow);</cell><cell>clinical records (office</cell><cell>visits, hospitalizations,</cell><cell>med changes)</cell><cell></cell><cell></cell><cell></cell><cell>Self-report</cell><cell></cell><cell></cell><cell></cell><cell>Self-report</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Exposure of</cell><cell>experimental and</cell><cell>control groups</cell><cell>EG: SMS med</cell><cell>reminders</cell><cell>CG: Standard</cell><cell>of care</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>EG: SMS med</cell><cell>reminders</cell><cell>CG: Standard</cell><cell>health info</cell><cell>EG: SMS on med</cell><cell>therapy and clinic</cell><cell>follow-up</cell><cell>CG: No SMS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>SMS med reminders</cell><cell>(3 per week) and</cell><cell>educational messages</cell><cell>(4 per week)</cell><cell>EG: 'Tailored' SMS</cell><cell>based on illness and</cell><cell>med beliefs</cell><cell>CG: No SMS</cell><cell></cell><cell></cell></row><row><cell>Design, sample size,</cell><cell>mean age (SD or</cell><cell>range), gender</cell><cell>RCT;</cell><cell>N = 254;</cell><cell>EG 38Á6 AE 10Á2</cell><cell>CG 40Á6 AE 11Á5;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>RCT;</cell><cell>N = 424;</cell><cell>26Á4 (no SD);</cell><cell>Male</cell><cell>RCT;</cell><cell>N = 16;</cell><cell>24Á6 AE 6Á5;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pilot, pre-post design;</cell><cell>N = 25;</cell><cell>30Á5 AE 13Á4;</cell><cell>Male &amp; female</cell><cell>RCT;</cell><cell>N = 216;</cell><cell>included 16-45</cell><cell>year olds;</cell><cell>Male &amp; female</cell><cell></cell></row><row><cell>Target condition</cell><cell>and duration of</cell><cell>study (months)</cell><cell>Schizophrenia</cell><cell>3 month of SMS;</cell><cell>follow-up at month 6</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Malaria</cell><cell>1 month</cell><cell></cell><cell></cell><cell>Asthma</cell><cell>16 weeks</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Atopic dermatitis</cell><cell>6 weeks</cell><cell></cell><cell></cell><cell>Asthma</cell><cell>18 week SMS</cell><cell>intervention;</cell><cell>up to 9-month</cell><cell>follow-up</cell><cell></cell></row><row><cell></cell><cell>First author,</cell><cell>year, Country</cell><cell>Montes (2012)</cell><cell>Spain</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Ollivier (2009)</cell><cell>France</cell><cell></cell><cell></cell><cell>Ostojic (2005)</cell><cell>Croatia</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pena-Robichaux</cell><cell>(2010) US</cell><cell></cell><cell></cell><cell>Petrie</cell><cell>(2012)</cell><cell>New Zealand</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 1 (</head><label>1</label><figDesc><div><p xml:id="_dqNDynv"><s xml:id="_gSfHwxm">Continued).</s></p></div></figDesc><table><row><cell>Results (med</cell><cell>adherence and/</cell><cell>or biomarker)</cell><cell>Significant difference in proportion of &gt;90%</cell><cell>adherence rate between EG and CG receiving</cell><cell>weekly SMS (53% vs. 40% respectively;</cell><cell>P = 0Á03) and less likely to have treatment</cell><cell>interruptions exceeding 48 hour (81% vs. 90%,</cell><cell>P = 0Á03). No differences between groups</cell><cell>receiving daily SMS.</cell><cell>No differences between groups receiving short</cell><cell>messages (P = 0Á24) or long messages with</cell><cell>encouraging messages (P = 0Á24).</cell><cell>Significant decrease in mean FPG (185 + 57 mg/dL</cell><cell>to 166 + 54, P &lt; 0Á002) and 2 hour PG</cell><cell>(263 + 84 mg/dL to 220 + 67, P &lt; 0Á002) in EG.</cell><cell>Significant change from baseline in 2 h PG</cell><cell>between EG and CG (14Á1-34Á6% vs.</cell><cell>13Á6-19Á7% respectively; P &lt; 0Á007). Significant</cell><cell>change from baseline in HbA1C between groups</cell><cell>(30Á8-55Á1%, 31Á8-48Á5% respectively;</cell><cell>P &lt; 0Á007). Med prescriptions 'were followed</cell><cell>satisfactorily by both groups.'</cell><cell>Significant absolute difference in mean adherence</cell><cell>rate between groups of 17Á8% (P = 0Á02).</cell><cell>Significant increase in mean adherence rate in EG</cell><cell>(77Á9% to 81Á5%, mean change = 3Á5%;</cell><cell>P = 0Á52). Significant decrease in mean adherence</cell><cell>rate in CG (84Á2% to 70Á1%, mean</cell><cell>change = À14Á2%; P = 0Á01).</cell><cell>No significant difference in adherence between EG</cell><cell>and CG (57% vs. 45% respectively; P = 0Á16).</cell><cell>No difference in proportion of those who had</cell><cell>filled prescriptions in first 24 hours between EG</cell><cell>and CG (78% vs. 69% respectively; P = 0Á26) or</cell><cell>proportion of those who had no pills left (68%</cell><cell>vs. 59% respectively; P = 0Á30).</cell></row><row><cell></cell><cell>Measures of</cell><cell>med adherence</cell><cell>MEMS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Fasting plasma glucose</cell><cell>(FPG), 2 hour</cell><cell>postprandial plasma</cell><cell>glucose (2 h PG) and</cell><cell>HbA1C; Adherence</cell><cell>to med, diet and</cell><cell>activity prescriptions</cell><cell></cell><cell></cell><cell></cell><cell>Med dose-count on the</cell><cell>discos Seretide â ,</cell><cell>pharmacy reports</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Self-report</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Exposure of</cell><cell>experimental and</cell><cell>control groups</cell><cell>EG: SMS med reminders:</cell><cell>daily vs. weekly,</cell><cell>short vs. long</cell><cell>CG: No SMS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>EG: 'Personalized' SMS</cell><cell>CG: Standard of care</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>EG: SMS med</cell><cell>reminders</cell><cell>CG: No SMS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>EG: SMS query about</cell><cell>prescription pickup</cell><cell>and dosage taken</cell><cell>with educational</cell><cell>feedback based on</cell><cell>responses</cell><cell>CG: Standard of care</cell></row><row><cell>Design, sample size,</cell><cell>mean age (SD or</cell><cell>range), gender</cell><cell>RCT;</cell><cell>N = 431;</cell><cell>Average age of 5</cell><cell>groups: 36Á2 (no SD);</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pilot RCT;</cell><cell>N = 215;</cell><cell>EG 50Á1 AE 9Á9,</cell><cell>CG 50Á5 AE 8Á3;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>RCT;</cell><cell>N = 26;</cell><cell>EG: 34Á4</cell><cell>CG: 30Á7</cell><cell>(no SD);</cell><cell>Male &amp; female</cell><cell></cell><cell>RCT;</cell><cell>N = 200;</cell><cell>33 AE 12;</cell><cell>Male &amp; female</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Target condition</cell><cell>and duration of</cell><cell>study (months)</cell><cell>HIV</cell><cell>4 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Diabetes</cell><cell>1 year</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Asthma</cell><cell>3 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Oral antibiotic</cell><cell>use from</cell><cell>emergency</cell><cell>department</cell><cell>Duration of</cell><cell>antibiotic use,</cell><cell>up to 2 weeks</cell></row><row><cell></cell><cell>First author,</cell><cell>year, Country</cell><cell>Pop-Eleches (2011)</cell><cell>Kenya</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Shetty (2011)</cell><cell>India</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Strandbygaard</cell><cell>(2010)</cell><cell>Denmark</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Suffoletto (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 1 (</head><label>1</label><figDesc><div><p xml:id="_FZjRHKb"><s xml:id="_G6xpJ8n">Continued).</s></p></div></figDesc><table><row><cell>Results (med</cell><cell>adherence and/</cell><cell>or biomarker)</cell><cell>No significant difference in self-reported adherence</cell><cell>between EG and CG (80% for both). 25% had</cell><cell>sufficiently high HCQ blood levels; 29% had</cell><cell>undetectable levels. 32% were adherent over 80%</cell><cell>of the time by pharmacy refill. Small effect size</cell><cell>(Cohen's d &lt; 0Á25) on adherence.</cell><cell>No significant difference in missed doses between</cell><cell>EG and CG (15% vs. 19% respectively;</cell><cell>P = 0Á07). No difference in days without dosing</cell><cell>between groups (P = 0Á28). EG took significantly</cell><cell>more doses within agreed time period than CG</cell><cell>(57% vs. 43% respectively; P = 0Á003).</cell><cell>Significant improvement of med adherence</cell><cell>P &lt; 0Á001, diet adherence P &lt; 0Á001 and physical</cell><cell>activity P &lt; 0Á001.</cell><cell>Significant changes in HbA1C for EG (P &lt; 0Á001)</cell><cell>and CG (P &lt; 0Á001) but no differences between</cell><cell>groups (P = 0Á19).</cell></row><row><cell></cell><cell>Measures of</cell><cell>med adherence</cell><cell>Self-report, blood levels</cell><cell>of HCQ and pharmacy</cell><cell>refill reports</cell><cell></cell><cell></cell><cell></cell><cell>RTMM electronic</cell><cell>monitoring system</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Self-report</cell><cell>HbA1C</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Exposure of</cell><cell>experimental and</cell><cell>control groups</cell><cell>EG: SMS on med</cell><cell>reminders</cell><cell>CG: Standard of care</cell><cell></cell><cell></cell><cell></cell><cell>EG: RTMM system</cell><cell>with electronic med</cell><cell>dispensers and</cell><cell>customized SMS only</cell><cell>if dispenser not opened</cell><cell>CG: RTMM without SMS</cell><cell>EG: educational SMS</cell><cell>CG: telephone contact at</cell><cell>least twice a week for</cell><cell>first month, then weekly</cell><cell></cell><cell></cell></row><row><cell>Design, sample size,</cell><cell>mean age (SD or</cell><cell>range), gender</cell><cell>RCT;</cell><cell>N = 41 (subset with</cell><cell>med adherence);</cell><cell>18Á6 AE 2Á5;</cell><cell>Male &amp; female</cell><cell></cell><cell>RCT;</cell><cell>N = 104;</cell><cell>EG: 54Á9 AE 6Á6</cell><cell>CG: 54Á6 AE 6Á9;</cell><cell>Male &amp; female</cell><cell></cell><cell>Quasi-experimental;</cell><cell>N = 77;</cell><cell>EG 51Á1</cell><cell>CG 53Á7</cell><cell>(no SD);</cell><cell>Male &amp; female</cell></row><row><cell>Target condition</cell><cell>and duration of</cell><cell>study (months)</cell><cell>Systematic lupus</cell><cell>erythematosus</cell><cell>14 months</cell><cell></cell><cell></cell><cell></cell><cell>Diabetes</cell><cell>6 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Diabetes</cell><cell>3 months</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>First author,</cell><cell>year, Country</cell><cell>Ting (2012)</cell><cell>US</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Vervloet (2012)</cell><cell>Netherlands</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Zolfaghari (2012)</cell><cell>Iran</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_7fTSUU5"><p><s xml:id="_MqJvPDK">2 h PG, 2 hour post prandial plasma glucose; CG, control group; CIT, conventional insulin therapy; EG, experimental group; FPG, fasting plasma glucose; FEV1, forced expiratory volume; HbA1C, Haemoglobin A1C; HCQ, hydroxyl-chloroquine; IIT, intensive insulin therapy; MAQ, Morisky Green Adherence Questionnaire; MMAS, Morisky Medication Adherence Scale; med, medication; MEMS, Medication Event Monitoring System; NS, non-significant; OCP, oral contraceptive pill; PDC, proportion of days covered; PEF, peak expiratory flow; PRD, pharmacy refill data; RCT, randomized controlled trial; RR, relative risk; RTMM, Real Time Medication Monitoring; SD, standard deviation; SMS, short message service (text message); VAS, Visual Analogue Scale.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 2</head><label>2</label><figDesc><div><p xml:id="_xpkdmvs"><s xml:id="_PdSj4yG">Tracking, message content, satisfaction of SMS interventions.</s></p></div></figDesc><table><row><cell>First author &amp;</cell><cell>Frequency of</cell><cell>Tracking (2-way</cell><cell></cell><cell></cell></row><row><cell>year</cell><cell>SMS</cell><cell>SMS) &amp; response</cell><cell>Message content</cell><cell>Satisfaction</cell></row><row><cell>Arora (2012)</cell><cell>Daily (9 am, 12 pm</cell><cell>Yes, 2-way response</cell><cell>SMS on 5 domains:</cell><cell>High satisfaction (90-100%)</cell></row><row><cell></cell><cell>and 6 pm); frequency</cell><cell>was only an option</cell><cell>educational/motivational,</cell><cell>in helpfulness of SMS</cell></row><row><cell></cell><cell>of med reminders was</cell><cell>with trivia SMS</cell><cell>med reminders, healthy</cell><cell>to take meds, enjoying SMS,</cell></row><row><cell></cell><cell>3 per week</cell><cell>(one per week)</cell><cell>living challenges, diabetes</cell><cell>wanting to continue SMS and</cell></row><row><cell></cell><cell></cell><cell>35% response to</cell><cell>trivia and links to free</cell><cell>recommending to others.</cell></row><row><cell></cell><cell></cell><cell>trivia SMS</cell><cell>diabetes management</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>tools.</cell><cell></cell></row><row><cell>Boker (2012)</cell><cell>Twice daily, tailored to</cell><cell>Yes</cell><cell>SMS started with</cell><cell>33% starting ignoring</cell></row><row><cell></cell><cell>participant preference</cell><cell>74% replied that</cell><cell>participant's name but</cell><cell>SMS after 2 weeks.</cell></row><row><cell></cell><cell>and time of med use</cell><cell>they had taken their</cell><cell>content identical</cell><cell>26% found SMS to</cell></row><row><cell></cell><cell></cell><cell>med (although it did</cell><cell>(med reminder).</cell><cell>be 'annoying.'</cell></row><row><cell></cell><cell></cell><cell>not coincide with</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>MEMS data)</cell><cell></cell><cell></cell></row><row><cell>Castano (2012)</cell><cell>Daily; time selected by</cell><cell>Yes, 12 of 180 (0Á07%)</cell><cell>47 educational messages</cell><cell>Participants satisfied with</cell></row><row><cell></cell><cell>participant and could</cell><cell>of messages were</cell><cell>on 6 domains (risks,</cell><cell>number (91%), content</cell></row><row><cell></cell><cell>be changed on website</cell><cell>2-way for quality</cell><cell>benefits, side effects, use,</cell><cell>(91%) and length</cell></row><row><cell></cell><cell></cell><cell>control purposes</cell><cell>effectiveness and</cell><cell>(91%) of messages.</cell></row><row><cell></cell><cell></cell><cell>Response rate not</cell><cell>mechanisms of action)</cell><cell></cell></row><row><cell></cell><cell></cell><cell>reported</cell><cell>that were repeated up</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>to 4 times, 12 2-way</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>messages for quality</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>control.</cell><cell></cell></row><row><cell>Cocosila (2009)</cell><cell>Dosing weaned down</cell><cell>Yes</cell><cell>Virtual friend named</cell><cell>Not reported</cell></row><row><cell></cell><cell>over 1 month</cell><cell>44%</cell><cell>'Tim'. SMS divided into</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>reminding-basic,</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>reminding-reinforcing</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>and reminding-</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>correcting.</cell><cell></cell></row><row><cell>da Costa (2012)</cell><cell>Every Sat, Sun and</cell><cell>No</cell><cell>'The UNIFESP informs:</cell><cell>Timing: 27% -should be</cell></row><row><cell></cell><cell>alternate working days</cell><cell></cell><cell>take good care of</cell><cell>closer to time of med</cell></row><row><cell></cell><cell>sent 30 minutes before</cell><cell></cell><cell>your health.'</cell><cell>intake. Content:</cell></row><row><cell></cell><cell>last required med dose</cell><cell></cell><cell></cell><cell>91% -SMS did not</cell></row><row><cell></cell><cell>in a day</cell><cell></cell><cell></cell><cell>need to be changed,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>9% -Yes, change the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>content of SMS daily.</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Usefulness: 64% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>SMS helped them to</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>remember the time to</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>take meds. 45% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>SMS provided incentive</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>to take care of health or</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>take meds; 27% -felt</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>like someone cared</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>about them.</cell></row><row><cell>Dick (2011)</cell><cell>Timing and frequency</cell><cell>Possible for participant</cell><cell>Recommendations for</cell><cell>94% of participants</cell></row><row><cell></cell><cell>of delivery selected</cell><cell>to respond</cell><cell>self-care including med</cell><cell>said that SMS helped</cell></row><row><cell></cell><cell>by participant</cell><cell>80% responses</cell><cell>adherence, foot care</cell><cell>them to avoid missing</cell></row><row><cell></cell><cell></cell><cell></cell><cell>and blood sugar</cell><cell>meds, 94% strongly</cell></row><row><cell></cell><cell></cell><cell></cell><cell>monitoring.</cell><cell>agreed that the system</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>was easy to use and</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>89% increased the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>frequency of foot</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>self-examinations.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 2 (</head><label>2</label><figDesc><div><p xml:id="_dyveEv5"><s xml:id="_HyEFAxv">Continued).</s></p></div></figDesc><table><row><cell>First author &amp;</cell><cell>Frequency of</cell><cell>Tracking (2-way</cell><cell></cell><cell></cell></row><row><cell>year</cell><cell>SMS</cell><cell>SMS) &amp; response</cell><cell>Message content</cell><cell>Satisfaction</cell></row><row><cell>Dowshen (2012)</cell><cell>Daily at time(s)</cell><cell>Yes</cell><cell>Participants designed</cell><cell>81% of participants</cell></row><row><cell></cell><cell>selected by</cell><cell>48% responses</cell><cell>personalized SMS</cell><cell>said that they would</cell></row><row><cell></cell><cell>participant</cell><cell></cell><cell>reminder at the</cell><cell>like to continue to</cell></row><row><cell></cell><cell></cell><cell></cell><cell>beginning of study.</cell><cell>receive SMS after</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Examples included:</cell><cell>the end of the study</cell></row><row><cell></cell><cell></cell><cell></cell><cell>'Don't forget!,'</cell><cell>and 95% indicated</cell></row><row><cell></cell><cell></cell><cell></cell><cell>'Reminder,' 'Superman</cell><cell>that SMS helped them</cell></row><row><cell></cell><cell></cell><cell></cell><cell>calling you,' 'Time for</cell><cell>'very much' to miss</cell></row><row><cell></cell><cell></cell><cell></cell><cell>fruit cocktail.'</cell><cell>fewer doses of meds.</cell></row><row><cell>Foreman (2012)</cell><cell>Type and frequency</cell><cell>No</cell><cell>For those who elected</cell><cell>Not reported</cell></row><row><cell></cell><cell>of message selected</cell><cell>N/A</cell><cell>med reminders, the</cell><cell></cell></row><row><cell></cell><cell>by participant</cell><cell></cell><cell>general daily reminder</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>read, 'Take your</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>medications today.'</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Option of dosage</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>specific reminders.</cell><cell></cell></row><row><cell>Franklin (2003)</cell><cell>Daily or twice daily</cell><cell>No, hotline number</cell><cell>Tailored SMS from</cell><cell>97% liked frequency</cell></row><row><cell></cell><cell></cell><cell>provided if needed</cell><cell>database (examples):</cell><cell>(daily or twice daily),</cell></row><row><cell></cell><cell></cell><cell></cell><cell>'Don't 4get 2 inject!',</cell><cell>20% complained about</cell></row><row><cell></cell><cell></cell><cell></cell><cell>'Do you have any</cell><cell>receiving the same</cell></row><row><cell></cell><cell></cell><cell></cell><cell>'carb counting'</cell><cell>message repeatedly.</cell></row><row><cell></cell><cell></cell><cell></cell><cell>questions for the</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>DiaBTs doctors or</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>dietitians?'</cell><cell></cell></row><row><cell>Granholm (2012)</cell><cell>Monday through</cell><cell>Yes</cell><cell>First question: 'Did</cell><cell>Participant were asked</cell></row><row><cell></cell><cell>Saturday in random</cell><cell>Question 1: Mean =</cell><cell>you take your meds</cell><cell>each Friday, ''How</cell></row><row><cell></cell><cell>order in morning,</cell><cell>86% AE 19%, Median</cell><cell>today?' Next 2</cell><cell>helpful were the text</cell></row><row><cell></cell><cell>afternoon and</cell><cell>= 93%. Questions 2-3:</cell><cell>questions depending</cell><cell>messages this week?''</cell></row><row><cell></cell><cell>evening; time within</cell><cell>Mean = 85% AE 21%</cell><cell>on response, 'Do meds</cell><cell>Overall, mean = 3Á15</cell></row><row><cell></cell><cell>a 2-hour window</cell><cell>and 85% AE 30%.</cell><cell>help you stay healthy?'</cell><cell>AE 0Á84; median = 3Á42</cell></row><row><cell></cell><cell>selected by participant</cell><cell>Median = 94% and 98%</cell><cell>or 'How can you</cell><cell>(moderately to very</cell></row><row><cell></cell><cell></cell><cell></cell><cell>remember?'</cell><cell>helpful). Participants</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>who had more</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>experience with the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>SMS intervention</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>increased the likelihood</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>of reporting the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>intervention was helpful.</cell></row><row><cell>Hardy (2011)</cell><cell>Daily reminder</cell><cell>Yes</cell><cell>Choice of following</cell><cell>Nine of 10 participants</cell></row><row><cell></cell><cell>matching med</cell><cell>Weeks 0-3: median</cell><cell>categories: news,</cell><cell>reported that they</cell></row><row><cell></cell><cell>dosing frequency</cell><cell>response rate 0Á78. Weeks</cell><cell>weather, celebrity</cell><cell>enjoyed receiving a</cell></row><row><cell></cell><cell></cell><cell>3-6: response rate 0Á62</cell><cell>news, humour, jokes,</cell><cell>content-tailored reminder</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Bible verses, word of</cell><cell>SMS. Only 1 participant,</cell></row><row><cell></cell><cell></cell><cell></cell><cell>the day, baseball,</cell><cell>whose content was Bible</cell></row><row><cell></cell><cell></cell><cell></cell><cell>basketball, or football</cell><cell>verses, said that the</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(able to change at</cell><cell>content helped motivate</cell></row><row><cell></cell><cell></cell><cell></cell><cell>weeks 3 and 6).</cell><cell>her in some way to take</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>meds.</cell></row><row><cell>Hou (2010)</cell><cell>Daily</cell><cell>No</cell><cell>'Please remember to</cell><cell>SMS reminder was useful</cell></row><row><cell></cell><cell></cell><cell></cell><cell>take your birth</cell><cell>with a median score of</cell></row><row><cell></cell><cell></cell><cell></cell><cell>control pills.'</cell><cell>8 on a 0-10 scale. 66%</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>said that the SMS</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>reminded them more</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>Table 2 (</head><label>2</label><figDesc><div><p xml:id="_Fbh8Grb"><s xml:id="_2zfzena">Continued).</s></p></div></figDesc><table><row><cell>First author &amp;</cell><cell>Frequency of</cell><cell>Tracking (2-way</cell><cell></cell><cell></cell></row><row><cell>year</cell><cell>SMS</cell><cell>SMS) &amp; response</cell><cell>Message content</cell><cell>Satisfaction</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>than 50% of the time</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>to take their meds. 86%</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>of women said that</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>they would continue</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>or consider using the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>reminder system. 97%</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>would recommend or</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>consider</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>recommending it to</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>others.</cell></row><row><cell>Lester (2010)</cell><cell>Weekly</cell><cell>Yes; Response was either:</cell><cell>'Mambo?'</cell><cell>98% reported wanting</cell></row><row><cell></cell><cell></cell><cell>'Sawa' (fine) or</cell><cell>(How are you?)</cell><cell>to continue the SMS</cell></row><row><cell></cell><cell></cell><cell>'Shida' (problem)</cell><cell></cell><cell>programme. 98%</cell></row><row><cell></cell><cell></cell><cell>fine (65%), problem (3%),</cell><cell></cell><cell>would recommend</cell></row><row><cell></cell><cell></cell><cell>no response (32%)</cell><cell></cell><cell>the programme to a</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>friend. In focus groups,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>patients reported that</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>they felt 'like someone</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>cares.'</cell></row><row><cell>Lewis (2012)</cell><cell>Daily for non-</cell><cell>Yes</cell><cell>Non-adherent: 'Stop,</cell><cell>93% reported 'always'</cell></row><row><cell></cell><cell>adherent;</cell><cell>Not reported</cell><cell>drop and pop.</cell><cell>reading the messages;</cell></row><row><cell></cell><cell>weekly for adherent</cell><cell></cell><cell>Take your meds now.'</cell><cell>76% reported 'liking'</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Adherent: 'He shoots!</cell><cell>the messages;</cell></row><row><cell></cell><cell></cell><cell></cell><cell>He scores! Perfect med</cell><cell>and 39% and 29%</cell></row><row><cell></cell><cell></cell><cell></cell><cell>adherence. Great job!'</cell><cell>reported the messages</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>being 'very' or</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>'somewhat' helpful</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>respectively.</cell></row><row><cell>Marquez</cell><cell>2 SMS per week</cell><cell>No</cell><cell>SMS to encourage a</cell><cell>Not reported</cell></row><row><cell>Contreras</cell><cell>on random days</cell><cell></cell><cell>dherence and educate on</cell><cell></cell></row><row><cell>(2004)</cell><cell>Mon-Fri between</cell><cell></cell><cell>lifestyle. Examples:</cell><cell></cell></row><row><cell></cell><cell>11 am-2 pm</cell><cell></cell><cell>'Do not stop taking your</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>blood pressure medicine</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>even when you are taking</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>other medicines or have</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>another illness.'</cell><cell></cell></row><row><cell>Mbuagbaw</cell><cell>Weekly</cell><cell>No, phone number was</cell><cell>Motivational messages</cell><cell>91% -SMS helped them</cell></row><row><cell>(2012)</cell><cell></cell><cell>provided if help needed</cell><cell>with a reminder component.</cell><cell>to remember to take</cell></row><row><cell></cell><cell></cell><cell>48 of 101 EG patients</cell><cell>Example: 'You are important</cell><cell>their meds, 35% -did</cell></row><row><cell></cell><cell></cell><cell>used feedback option</cell><cell>to your family. Please</cell><cell>not want to continue</cell></row><row><cell></cell><cell></cell><cell></cell><cell>remember to take your</cell><cell>receiving SMS. 12% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell>medication. You can call</cell><cell>SMS excellent, 30% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell>us at this number:</cell><cell>very good, 21% -good,</cell></row><row><cell></cell><cell></cell><cell></cell><cell>+237 xxxx xxxx.'</cell><cell>17% -average, 5% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>bad, 16% -very bad.</cell></row><row><cell>Miloh (2009)</cell><cell>Once or twice daily</cell><cell>Yes, if patient did not</cell><cell>'Take [name of med] at</cell><cell>Not reported</cell></row><row><cell></cell><cell>matching med</cell><cell>respond within 15-60</cell><cell>[set time]. To confirm</cell><cell></cell></row><row><cell></cell><cell>dosing times</cell><cell>minutes, SMS sent to</cell><cell>intake, press REPLY,</cell><cell></cell></row><row><cell></cell><cell></cell><cell>caregiver</cell><cell>type CARE 1 and press</cell><cell></cell></row><row><cell></cell><cell></cell><cell>Not reported</cell><cell>SEND.'</cell><cell></cell></row><row><cell>Montes (2012)</cell><cell>Daily; participant</cell><cell>No</cell><cell>'Please remember to take</cell><cell>Not reported</cell></row><row><cell></cell><cell>selected either</cell><cell></cell><cell>your medication.'</cell><cell></cell></row><row><cell></cell><cell>11 am or 2 pm</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>Table 2 (</head><label>2</label><figDesc><div><p xml:id="_5dAnePn"><s xml:id="_8kCgDN9">Continued).</s></p></div></figDesc><table><row><cell>First author &amp;</cell><cell>Frequency of</cell><cell>Tracking (2-way</cell><cell></cell><cell></cell></row><row><cell>year</cell><cell>SMS</cell><cell>SMS) &amp; response</cell><cell>Message content</cell><cell>Satisfaction</cell></row><row><cell>Ollivier (2009)</cell><cell>Daily</cell><cell>No</cell><cell>'Remember to take your</cell><cell>Overall satisfaction with</cell></row><row><cell></cell><cell></cell><cell></cell><cell>doxycycline pill at midday.'</cell><cell>reports that SMS was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>very useful,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>generalizable and was</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>not laborious.</cell></row><row><cell>Ostojic (2005)</cell><cell>Weekly</cell><cell>EG sent SMS to researcher</cell><cell>SMS on adjustments of</cell><cell>SMS were convenient</cell></row><row><cell></cell><cell></cell><cell>(PEF values) daily -99%</cell><cell>therapy and recommended</cell><cell>and non-intrusive.</cell></row><row><cell></cell><cell></cell><cell>compliant</cell><cell>follow-up with monitoring</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>physician.</cell><cell></cell></row><row><cell>Pena-Robichaux</cell><cell>Daily; time between</cell><cell>No</cell><cell>SMS with med reminders</cell><cell>Participants rated the</cell></row><row><cell>(2010)</cell><cell>7-9 am or 4-6 pm</cell><cell></cell><cell>with alternating</cell><cell>SMS system a mean</cell></row><row><cell></cell><cell>selected by participant</cell><cell></cell><cell>educational content and</cell><cell>score of 7Á1 AE 2Á4</cell></row><row><cell></cell><cell></cell><cell></cell><cell>option of additional</cell><cell>(scale from 1-10). 88% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell>'fun' SMS or 'hook'</cell><cell>SMS were helpful, 92% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell>with choice of forecast,</cell><cell>educational SMS were</cell></row><row><cell></cell><cell></cell><cell></cell><cell>sports scores or</cell><cell>helpful, 84% -want to</cell></row><row><cell></cell><cell></cell><cell></cell><cell>celebrity gossip.</cell><cell>continue the system,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>84% -would</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>recommend the SMS</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>programme to a friend,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>72% -willing to pay</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>a small monthly fee</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>for service.</cell></row><row><cell>Petrie (2012)</cell><cell>weeks 1-6: 2 daily</cell><cell>No</cell><cell>SMS based on baseline</cell><cell>Not reported</cell></row><row><cell></cell><cell>weeks 7-12: 1 daily</cell><cell></cell><cell>scores on Brief Illness</cell><cell></cell></row><row><cell></cell><cell>weeks 13-18: 3 per</cell><cell></cell><cell>Perception Questionnaire</cell><cell></cell></row><row><cell></cell><cell>week</cell><cell></cell><cell>and level of med belief</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>ratings. Example med</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>SMS: 'Your preventer</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>medication is not</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>addictive.'</cell><cell></cell></row><row><cell>Pop-Eleches (2011)</cell><cell>Daily compared with</cell><cell>No</cell><cell>Short message: 'This is</cell><cell>Not reported</cell></row><row><cell></cell><cell>weekly at 12 pm</cell><cell></cell><cell>your reminder.' Long</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>message: 'This is your</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>reminder. Be strong and</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>courageous, we care</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>about you.'</cell><cell></cell></row><row><cell>Shetty (2011)</cell><cell>Frequency chosen by</cell><cell>No</cell><cell>Content chosen by</cell><cell>Not reported</cell></row><row><cell></cell><cell>participant; median</cell><cell></cell><cell>participant. SMS on</cell><cell></cell></row><row><cell></cell><cell>frequency was</cell><cell></cell><cell>medical nutrition</cell><cell></cell></row><row><cell></cell><cell>2 SMS per week</cell><cell></cell><cell>therapy, physical</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>activity, med reminders</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>and general healthy</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>living habits.</cell><cell></cell></row><row><cell>Strandbygaard</cell><cell>Daily at 10 am</cell><cell>No</cell><cell>'Remember to take</cell><cell>Perception of receiving</cell></row><row><cell>(2010)</cell><cell></cell><cell></cell><cell>your asthma medication</cell><cell>daily SMS was positive,</cell></row><row><cell></cell><cell></cell><cell></cell><cell>morning and evening.</cell><cell>although majority</cell></row><row><cell></cell><cell></cell><cell></cell><cell>From the Respiratory Unit.'</cell><cell>found 10 am as</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>unsuitable. EG reported</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>SMS became comparable</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>to a simple alarm clock</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>on a mobile phone</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>after some weeks.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_10"><head>Table 2 (</head><label>2</label><figDesc><div><p xml:id="_qBUySux"><s xml:id="_QvUWwCE">Continued).</s></p></div></figDesc><table><row><cell>First author &amp;</cell><cell>Frequency of</cell><cell>Tracking (2-way</cell><cell></cell><cell></cell></row><row><cell>year</cell><cell>SMS</cell><cell>SMS) &amp; response</cell><cell>Message content</cell><cell>Satisfaction</cell></row><row><cell>Suffoletto (2012)</cell><cell>One hour after</cell><cell>Yes</cell><cell>Initial SMS: 'Welcome</cell><cell>91% reported SMS</cell></row><row><cell></cell><cell>antibiotic prescribed</cell><cell>67% replied to the</cell><cell>to the IMPACT antibiotic</cell><cell>was at least somewhat</cell></row><row><cell></cell><cell>and 24 hours after</cell><cell>antibiotic pickup</cell><cell>study. Text back 'yes' when</cell><cell>useful to remind them</cell></row><row><cell></cell><cell>participant response</cell><cell>question</cell><cell>you have picked up your</cell><cell>to pick up their</cell></row><row><cell></cell><cell></cell><cell></cell><cell>prescription for [Antibiotic].'</cell><cell>antibiotics. 52%</cell></row><row><cell></cell><cell></cell><cell></cell><cell>If no reply, extra SMS.</cell><cell>reported it was very</cell></row><row><cell></cell><cell></cell><cell></cell><cell>24 hours after response:</cell><cell>useful.</cell></row><row><cell></cell><cell></cell><cell></cell><cell>'IMPACT antibiotic study:</cell><cell>97% reported that</cell></row><row><cell></cell><cell></cell><cell></cell><cell>How many doses of</cell><cell>SMS was at least</cell></row><row><cell></cell><cell></cell><cell></cell><cell>[Antibiotic] did you take</cell><cell>somewhat useful to</cell></row><row><cell></cell><cell></cell><cell></cell><cell>between [0:00 PM] yesterday</cell><cell>remind them to take</cell></row><row><cell></cell><cell></cell><cell></cell><cell>and [0:00 PM] today?'</cell><cell>their antibiotics,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>with 61% who</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>reported it was very</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>useful.</cell></row><row><cell>Ting (2012)</cell><cell>Once daily med -</cell><cell>No</cell><cell>Example: 'Take ur HCQ</cell><cell>Participants initially</cell></row><row><cell></cell><cell>8 am; twice daily</cell><cell></cell><cell>now,' 'It's time 4ur meds.'</cell><cell>gave informal positive</cell></row><row><cell></cell><cell>med -8 am and 8 pm</cell><cell></cell><cell></cell><cell>feedback at follow-up</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>clinic visits.</cell></row><row><cell>Vervloet (2012)</cell><cell>SMS only if dispenser</cell><cell>No</cell><cell>'Have you taken your</cell><cell>EG reported more</cell></row><row><cell></cell><cell>not opened (reminded</cell><cell></cell><cell>medication yet? Please take</cell><cell>awareness of med use</cell></row><row><cell></cell><cell>for 36% of all</cell><cell></cell><cell>your medication as prescribed</cell><cell>compared with CG</cell></row><row><cell></cell><cell>prescribed doses)</cell><cell></cell><cell>by your health care provider.'</cell><cell>(P = 0Á04). Accuracy in</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>taking med was not</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>significant (P = 0Á10).</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>83% -'It is good to</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>know I am reminded</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>if needed,' 75% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>'SMS reminders</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>support me in med</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>use,' 18% -'I do not</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>react to the SMS</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>reminders,' 21% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>'SMS reminders are</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>disturbing,' 66% -</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>'SMS reminders are</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>useful.'</cell></row><row><cell>Zolfaghari</cell><cell>6 SMS every week</cell><cell>No</cell><cell>Messages set in 3 priorities:</cell><cell>Not reported</cell></row><row><cell>(2012)</cell><cell>(except holidays)</cell><cell></cell><cell>diet adherence, med</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>adherence and stress</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>management.</cell><cell></cell></row><row><cell cols="5">CG, control group; EG, experimental group; med, medication; N/A, not applicable; PEF, peak expiratory flow; SMS, short message service</cell></row><row><cell>(text message).</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_yxZESzS"><s xml:id="_6xRGR7c">© 2014 John Wiley &amp; Sons Ltd</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_AZhqvMh"><s xml:id="_VKa3h6V">© 2014 John Wiley &amp; Sons Ltd</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_wFqQQFT"><s xml:id="_Qv3SueP">13652648, 2014, 9, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jan.12400</s><s xml:id="_kmJsEK9">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [14/08/2025].</s><s xml:id="_WujdzrU">See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions)</s><s xml:id="_jy5fvHQ">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_X7xjPPZ"><s xml:id="_WCZKTcm">© 2014 John Wiley &amp; Sons Ltd L.G. Park et al.13652648, 2014, 9, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jan.12400</s><s xml:id="_rtvXTjg">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [14/08/2025].</s><s xml:id="_DQ3YbTP">See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions)</s><s xml:id="_RFa3JQt">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HpYUNX5">Author contributions</head><p xml:id="_SkqbNrm"><s xml:id="_F6XAfU2">The authors have confirmed that all authors meet the ICMJE criteria for authorship credit (<ref type="url" target="www.icmje.org/ethi-">www.icmje.org/ethi-</ref>cal_1author.html),</s><s xml:id="_5sBeUHF">as follows:</s></p><p xml:id="_G8WPncA"><s xml:id="_3sTRFgc">• substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data,</s></p><p xml:id="_yYnZMMN"><s xml:id="_jshxuM4">• drafting the article or revising it critically for important intellectual content and</s></p><p xml:id="_pqVT75S"><s xml:id="_7gtHVSG">• final approval of the version to be published.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_X7PvADV">Supporting Information Online</head><p xml:id="_We4UPes"><s xml:id="_ZZY3daG">Additional Supporting Information may be found in the online version of this article:</s></p><p xml:id="_au8uuJh"><s xml:id="_Yh5tymD">Table <ref type="table">S1</ref>.</s><s xml:id="_bs4fad4">Risk of bias assessment.</s><s xml:id="_7ywrsqM">Table <ref type="table">S2</ref>.</s><s xml:id="_DUmYYMa">Criteria met for risk of bias assessment.</s><s xml:id="_3V3bX7b">The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective?</s><s xml:id="_sFxgSYh">Journal of Clinical Nursing 21 <ref type="bibr">(13-14), 1922-1931. doi:10.1111/ j.1365-2702.2011.03951.</ref>x.</s></p><p xml:id="_xwBARBf"><s xml:id="_wbVS4Ba">The Journal of Advanced Nursing (JAN) is an international, peer-reviewed, scientific journal.</s><s xml:id="_MMra5h4">JAN contributes to the advancement of evidence-based nursing, midwifery and health care by disseminating high quality research and scholarship of contemporary relevance and with potential to advance knowledge for practice, education, management or policy.</s><s xml:id="_cGaMhKn">JAN publishes research reviews, original research reports and methodological and theoretical papers.</s></p><p xml:id="_YCRm7n7"><s xml:id="_e5w7ymD">For further information, please visit JAN on the Wiley Online Library website: <ref type="url" target="www.wileyonlinelibrary.com/journal/jan">www.wileyonlinelibrary.com/journal/jan</ref></s></p><p xml:id="_zeHpMwj"><s xml:id="_Rc7ZkjB">Reasons to publish your work in JAN:</s></p><p xml:id="_P3CTehK"><s xml:id="_caQuRAC">• High-impact forum: the world's most cited nursing journal, with an Impact Factor of 1•527ranked 14/101 in the 2012 ISI Journal Citation Reports © (Nursing (Social Science)).</s></p><p xml:id="_j5C2WeU"><s xml:id="_4X2aJAq">• Most read nursing journal in the world: over 3 million articles downloaded online per year and accessible in over 10,000 libraries worldwide (including over 3,500 in developing countries with free or low cost access).</s></p><p xml:id="_ePT5gSV"><s xml:id="_ykyWJgC">• Fast and easy online submission: online submission at <ref type="url" target="http://mc.manuscriptcentral.com/jan">http://mc.manuscriptcentral.com/jan</ref>.</s></p><p xml:id="_FHUJMVV"><s xml:id="_jauQSc8">• Positive publishing experience: rapid double-blind peer review with constructive feedback.</s></p><p xml:id="_UfBRqSQ"><s xml:id="_CCmNqve">• Rapid online publication in five weeks: average time from final manuscript arriving in production to online publication.</s></p><p xml:id="_YzYCjhX"><s xml:id="_suKfKCG">• Online Open: the option to pay to make your article freely and openly accessible to non-subscribers upon publication on Wiley Online Library, as well as the option to deposit the article in your own or your funding agency's preferred archive (e.g.</s><s xml:id="_AeSYMC6">PubMed).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_QKwANa5">A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program</title>
		<author>
			<persName><forename type="first">S</forename><surname>Arora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Agy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Menchine</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2011.0252</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pjuAZCu">Diabetes Technology and Therapeutics</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="492" to="496" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Arora S., Peters A.L., Agy C. &amp; Menchine M. (2012) A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program. Diabetes Technology and Therapeutics 14(6), 492-496. doi:10.1089/dia. 2011.0252.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_R4UCqqU">Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Boker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Feetham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Purcell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jacobe</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaad.2012.02.031</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eB3Q44R">Journal of American Academy of Dermatology</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1136" to="1142" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Boker A., Feetham H.J., Armstrong A., Purcell P. &amp; Jacobe H. (2012) Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial. Journal of American Academy of Dermatology 67(6), 1136-1142. doi:10. 1016/j.jaad.2012.02.031.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_SKmBGE7">Medication adherence: A call for action</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Granger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mendys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brindis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Burkholder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Czajkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Daniel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ekman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Kimmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Musaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Shrank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Buono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Granger</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2011.06.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PxTnYqY">American Heart Journal</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="412" to="424" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bosworth H.B., Granger B.B., Mendys P., Brindis R., Burkholder R., Czajkowski S.M., Daniel J.G., Ekman I., Ho M., Johnson M., Kimmel S.E., Liu L.Z., Musaus J., Shrank W.H., Buono E.W., Weiss K. &amp; Granger C.B. (2011) Medication adherence: A call for action. American Heart Journal 162(3), 412-424. doi:10. 1016/j.ahj.2011.06.007.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_f2ubXvB">Medication adherence: WHO cares?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Bussell</surname></persName>
		</author>
		<idno type="DOI">10.4065/mcp.2010.0575</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y38gpkj">Mayo Clinic Proceedings</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="304" to="314" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brown M.T. &amp; Bussell J.K. (2011) Medication adherence: WHO cares? Mayo Clinic Proceedings 86(4), 304-314. doi:10.4065/ mcp.2010.0575.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_qTGb4MY">Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Castano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Bynum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Andres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Westhoff</surname></persName>
		</author>
		<idno type="DOI">10.1097/aog.0b013e31823d4167</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h8sMrUA">Obstetrics and Gynecology</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="14" to="20" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Castano P.M., Bynum J.Y., Andres R., Lara M. &amp; Westhoff C. (2012) Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial. Obstetrics and Gynecology 119(1), 14-20. doi:10.1097/AOG.0b013e31823d 4167.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<idno type="DOI">10.1007/978-1-4020-5614-7_348</idno>
		<ptr target="http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf" />
		<title level="m" xml:id="_CYsDSKY">Systematic reviews. CRD guidance for undertaking reviews in health care</title>
		<imprint>
			<publisher>Centre for Reviews and Dissemination</publisher>
			<date type="published" when="2008-12-10">2008. 10 December 2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Centre for Reviews and Dissemination (2008) Systematic reviews. CRD guidance for undertaking reviews in health care. Retrieved from http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf on 10 December 2012.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<idno type="DOI">10.1002/chp.1340210109</idno>
		<ptr target="http://epoc.cochrane.org/epoc-author-resourceson20" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_mDcJ75X">Cochrane Effective Practice and Organisation of Care Group</title>
		<title level="s" xml:id="_cKsEJxb">Epoc Author Resources</title>
		<imprint>
			<date type="published" when="2012-12">2012. December 2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cochrane Effective Practice and Organisation of Care Group (2012) Epoc Author Resources. Retrieved from http://epoc. cochrane.org/epoc-author-resources on 20 December 2013.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_NzNvFbb">Can wireless text messaging improve adherence to preventive activities? Results of a randomised controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cocosila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Archer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Yuan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijmedinf.2008.07.011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YRRhxpc">International Journal of Medical Informatics</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="230" to="238" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cocosila M., Archer N., Haynes R.B. &amp; Yuan Y.F. (2009) Can wireless text messaging improve adherence to preventive activities? Results of a randomised controlled trial. International Journal of Medical Informatics 78(4), 230-238. doi:10.1016/j. ijmedinf.2008.07.011.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_AF6azR7">Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDSinfected Brazilian women and impressions and satisfaction with respect to incoming messages</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Da Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Barbosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Gomes E Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sigulem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fatima</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Marin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Filho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Pisa</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijmedinf.2011.10.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9gUyTNV">International Journal of Medical Informatics</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="257" to="269" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">da Costa T.M., Barbosa B.J., Gomes e Costa D.A., Sigulem D., de Fatima Marin H., Filho A. C. &amp; Pisa I.T. (2012) Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS- infected Brazilian women and impressions and satisfaction with respect to incoming messages. International Journal of Medical Informatics 81(4), 257-269. doi:10.1016/j.ijmedinf.2011.10.002.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_qkF6m56">Feasibility and usability of a text messagebased program for diabetes self-management in an urban African-American population</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Dick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nundy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Chin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Peek</surname></persName>
		</author>
		<idno type="DOI">10.1177/193229681100500534</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PZyvMUa">Journal of Diabetes Science and Technology</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1246" to="1254" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dick J.J., Nundy S., Solomon M.C., Bishop K.N., Chin M.H. &amp; Peek M.E. (2011) Feasibility and usability of a text message- based program for diabetes self-management in an urban African-American population. Journal of Diabetes Science and Technology 5(5), 1246-1254.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_tFQ5H8J">Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders</title>
		<author>
			<persName><forename type="first">N</forename><surname>Dowshen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Kuhns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Holoyda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Garofalo</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.2015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h5GqbYv">Journal of Medical Internet Research</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">51</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dowshen N., Kuhns L.M., Johnson A., Holoyda B.J. &amp; Garofalo R. (2012) Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. Journal of Medical Internet Research 14(2), e51. doi:10.2196/jmir.2015.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_2VSJbXq">Behavior change interventions delivered by mobile telephone short-message service</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Fjeldsoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2008.09.040</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AdEKTA7">American Journal of Preventive Medicine</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="165" to="173" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fjeldsoe B.S., Marshall A.L. &amp; Miller Y.D. (2009) Behavior change interventions delivered by mobile telephone short-message service. American Journal of Preventive Medicine 36(2), 165- 173. doi:10.1016/j.amepre.2008.09.040.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_jyYajE3">Impact of a text messaging pilot program on patient medication adherence</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Foreman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Stockl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fisk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Lew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Solow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Curtis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.clinthera.2012.04.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GwQe49X">Clinical Therapeutics</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1084" to="1091" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foreman K.F., Stockl K.M., Le L.B., Fisk E., Shah S.M., Lew H.C., Solow B.K. &amp; Curtis B.S. (2012) Impact of a text messaging pilot program on patient medication adherence. Clinical Therapeutics 34(5), 1084-1091. doi:10.1016/j.clinthera.2012.04. 007.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_KnbJgq6">Sweet Talk&apos;: text messaging support for intensive insulin therapy for young people with diabetes</title>
		<author>
			<persName><forename type="first">V</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Waller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pagliari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Greene</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-5491.2006.01989.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nWTxNdh">Diabetes Technology and Therapeutics</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="991" to="996" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Franklin V., Waller A., Pagliari C. &amp; Greene S. (2003) &apos;Sweet Talk&apos;: text messaging support for intensive insulin therapy for young people with diabetes. Diabetes Technology and Therapeutics 5(6), 991-996. doi:10.1111/j.1464-5491.2006. 01989.x.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_NMDb92h">Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization and auditory hallucinations</title>
		<author>
			<persName><forename type="first">E</forename><surname>Granholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ben-Zeev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Link</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Bradshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Holden</surname></persName>
		</author>
		<idno type="DOI">10.1093/schbul/sbr155</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_N7QeG3y">Schizophrenia Bulletin</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="414" to="425" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Granholm E., Ben-Zeev D., Link P.C., Bradshaw K.R. &amp; Holden J.L. (2012) Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization and auditory hallucinations. Schizophrenia Bulletin 38(3), 414-425. doi:10. 1093/schbul/sbr155.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_6xhgktc">Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Doros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Drainoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rybin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Myung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Backman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stanic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Skolnik</surname></persName>
		</author>
		<idno type="DOI">10.1089/apc.2010.0006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_C4st75R">AIDS Patient Care and STDs</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="153" to="161" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hardy H., Kumar V., Doros G., Farmer E., Drainoni M.L., Rybin D., Myung D., Jackson J., Backman E., Stanic A. &amp; Skolnik P.R. (2011) Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care and STDs 25(3), 153-161. doi:10. 1089/apc.2010.0006.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_gMR2dvZ">Interventions for enhancing medication adherence</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ackloo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sahota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mcdonald</forename><surname>Heather</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P &amp;</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd000011.pub3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xtet8fj">Cochrane Database of Systematic Reviews</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haynes RB, Ackloo E, Sahota N, McDonald Heather P &amp; Yao X. (2008) Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2, CD000011. doi: 10.1002/14651858.CD000011.pub3.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_U7EjqhJ">Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hurwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kavanagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fortin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Goldberg</surname></persName>
		</author>
		<idno type="DOI">10.1097/aog.0b013e3181eb6b0f</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sPJq3HG">Obstetrics and Gynecology</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="633" to="640" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hou M.Y., Hurwitz S., Kavanagh E., Fortin J. &amp; Goldberg A.B. (2010) Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstetrics and Gynecology 116(3), 633-640. doi:10.1097/AOG. 0b013e3181eb6b0f.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_UH63JMj">Electronic measurement of medication adherence in pediatric chronic illness: a review of measures</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Ingerski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Hente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Modi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hommel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpeds.2011.05.018</idno>
		<ptr target="http://www.itu.int/ITUD/ict/facts/2011/material/ICTFactsFigures2011.pdf" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_C32K22e">The World in 2011: ICT Facts and Figures</title>
		<imprint>
			<publisher>International Telecommunication Union</publisher>
			<date type="published" when="2011-01-04">2011. 2011. 04 January 2012</date>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="528" to="534" />
		</imprint>
	</monogr>
	<note type="raw_reference">Ingerski L.M., Hente E.A., Modi A.C. &amp; Hommel K.A. (2011) Electronic measurement of medication adherence in pediatric chronic illness: a review of measures. The Journal of Pediatrics 159(4), 528-534. doi:10.1016/j.jpeds.2011.05.018. International Telecommunication Union (2011) The World in 2011: ICT Facts and Figures. Retrieved from http://www.itu.int/ ITUD/ict/facts/2011/material/ICTFactsFigures2011.pdf on 04 January 2012.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_7d6XErd">Mobile phone messaging for facilitating selfmanagement of long-term illnesses</title>
		<author>
			<persName><forename type="first">T</forename><surname>De Jongh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gurol-Urganci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vodopivec-Jamsek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Car</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Atun</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd007459.pub2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sSwYRJN">Cochrane Database of Systemic Reviews</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">7459</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Jongh T., Gurol-Urganci I., Vodopivec-Jamsek V., Car J. &amp; Atun R. (2012) Mobile phone messaging for facilitating self- management of long-term illnesses. Cochrane Database of Systemic Reviews 12, CD007459. doi: 10.1002/ 14651858.CD007459.pub2</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_be42fAw">Healthcare via cell phones: a systematic review</title>
		<author>
			<persName><forename type="first">Krishna</forename><forename type="middle">S</forename><surname>Boren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Balas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2008.0099</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zbNPSQQ">Telemedicine Journal and e-Health</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="231" to="240" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Krishna S., Boren S.A. &amp; Balas E.A. (2009) Healthcare via cell phones: a systematic review. Telemedicine Journal and e-Health 15(3), 231-240. doi:10.1089/tmj.2008.0099.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_Hm53ZNt">H_pe for mHealth: more &apos;y&apos; or &apos;o&apos; on the horizon</title>
		<author>
			<persName><forename type="first">A</forename><surname>Labrique</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Vasudevan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mehl</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijmedinf.2012.11.016</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cDwhEWX">International Journal of Medical Informatics</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="467" to="469" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Labrique A., Vasudevan L., Chang L.W. &amp; Mehl G. (2013) H_pe for mHealth: more &apos;y&apos; or &apos;o&apos; on the horizon? International Journal of Medical Informatics 82(5), 467-469. doi:10.1016/j. ijmedinf.2012.11.016.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_aFceKmh">Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Lester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ritvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kariri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Karanja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Habyarimana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadatsafavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Najafzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Marra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Estambale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ngugi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Ball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thabane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Gelmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kimani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ackers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Plummer</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(10)61997-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_X2VpAEz">Lancet</title>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="page" from="1838" to="1845" />
			<date type="published" when="2010">2010. 9755</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lester R.T., Ritvo P., Mills E.J., Kariri A., Karanja S., Chung M.H., Jack W., Habyarimana J., Sadatsafavi M., Najafzadeh M., Marra C.A., Estambale B., Ngugi E., Ball T.B., Thabane L., Gelmon L.J., Kimani J., Ackers M. &amp; Plummer F.A. (2010) Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 376(9755), 1838-1845. doi:10.1016/s0140-6736 (10)61997-6.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_wjaqaYS">Tailored text messaging intervention for HIV adherence: a proof-of-concept study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Uhrig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Furberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coomes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Kuhns</surname></persName>
		</author>
		<idno type="DOI">10.1037/a0028109</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_f7VEEac">Health Psychology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="248" to="253" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lewis M.A., Uhrig J.D., Bann C.M., Harris J.L., Furberg R.D., Coomes C. &amp; Kuhns L.M. (2012) Tailored text messaging intervention for HIV adherence: a proof-of-concept study. Health Psychology 32(3), 248-253. doi:10.1037/a0028109.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_MUt7aM4">Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert)</title>
		<author>
			<persName><forename type="first">Marquez</forename><surname>Contreras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>De La Figuera Von Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Gil</forename><surname>Guillen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ylla-Catala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Figueras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Balana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Naval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<idno>doi: 13068215</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fGpHsXa">Atenci on Primaria</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="399" to="405" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marquez Contreras E., de la Figuera von Wichmann M., Gil Guillen V., Ylla-Catala A., Figueras M., Balana M. &amp; Naval J. (2004) Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert). Atenci on Primaria 34 (8), 399-405. doi: 13068215</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_5JnDmJa">The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mbuagbaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thabane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ongolo-Zogo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Lester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Smieja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dolovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kouanfack</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0046909</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_N4n2PHz">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">46909</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mbuagbaw L., Thabane L., Ongolo-Zogo P., Lester R.T., Mills E.J., Smieja M., Dolovich L. &amp; Kouanfack C. (2012) The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS ONE 7(12), e46909. doi:10.1371/ journal.pone.0046909.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_3mejsWy">Randomized, crossover evaluation of mobile phone vs. paper diary in subjects with mild to moderate persistent asthma</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Meltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kelley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Hovell</surname></persName>
		</author>
		<idno type="DOI">10.2174/1874306400802010072</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KyAN2Mq">The Open Respiratory Medicine Journal</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="72" to="79" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Meltzer E.O., Kelley N. &amp; Hovell M.F. (2008) Randomized, cross- over evaluation of mobile phone vs. paper diary in subjects with mild to moderate persistent asthma. The Open Respiratory Medicine Journal 2, 72-79. doi:10.2174/1874306400802010072.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_QamX4kv">Systematic review of text-messaging interventions to promote healthy behaviors in pediatric and adolescent populations: implications for clinical practice and research</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Militello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Melnyk</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1741-6787.2011.00239.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_q3SQJGE">Worldviews on Evidence-Based Nursing</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="66" to="77" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Militello L.K., Kelly S.A. &amp; Melnyk B.M. (2012) Systematic review of text-messaging interventions to promote healthy behaviors in pediatric and adolescent populations: implications for clinical practice and research. Worldviews on Evidence-Based Nursing 9 (2), 66-77. doi:10.1111/j.1741-6787.2011.00239.x.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_ujprsnT">Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging</title>
		<author>
			<persName><forename type="first">T</forename><surname>Miloh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Annunziato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arnon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Warshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Parkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Suchy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Iyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kerkar</surname></persName>
		</author>
		<idno type="DOI">10.1542/peds.2009-0415</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NjgcXhF">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="844" to="e850" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miloh T., Annunziato R., Arnon R., Warshaw J., Parkar S., Suchy F.J., Iyer K. &amp; Kerkar N. (2009) Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 124(5), e844-e850. doi:10.1542/peds. 2009-0415.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_2KUKKJv">A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Montes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Medina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gomez-Beneyto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Maurino</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psychres.2012.07.034</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cjF94Qt">Psychiatry Research</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="issue">2-3</biblScope>
			<biblScope unit="page" from="89" to="95" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Montes J.M., Medina E., Gomez-Beneyto M. &amp; Maurino J. (2012) A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Research 200(2-3), 89-95. doi:10.1016/j.psychres. 2012.07.034.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main" xml:id="_h3NfEQ4">NEHI research shows patient medication nonadherence costs health care system $290 billion annually</title>
		<idno type="DOI">10.1037/e556062006-001</idno>
		<ptr target="http://www.nehi.net/news/press_releases/110/nehi_research_shows_patient_medication_nonadherence_costs_health_care_system_290_billion_annuallyon30" />
		<imprint>
			<date type="published" when="2009-10">2009. October 2009</date>
			<publisher>New England Health Institute</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">New England Health Institute (2009) NEHI research shows patient medication nonadherence costs health care system $290 billion annually. Retrieved from http://www.nehi.net/news/press_releases/ 110/nehi_research_shows_patient_medication_nonadherence_ costs_health_care_system_290_billion_annually on 30 October 2009.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_xxfCWMk">Advancing the science of mHealth</title>
		<author>
			<persName><forename type="first">W</forename><surname>Nilsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Varoquiers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wiley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pavel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Atienza</surname></persName>
		</author>
		<idno type="DOI">10.1080/10810730.2012.677394</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_J7cemZC">Journal of Health Communication</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">Suppl 1</biblScope>
			<biblScope unit="page" from="5" to="10" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nilsen W., Kumar S., Shar A., Varoquiers C., Wiley T., Riley W.T., Pavel M. &amp; Atienza A.A. (2012) Advancing the science of mHealth. Journal of Health Communication 17(Suppl 1), 5-10. doi:10.1080/10810730.2012.677394.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_GzUjBvu">Use of short message service (SMS) to improve malaria chemoprophylaxis compliance after returning from a malaria endemic area</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ollivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Romand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Marimoutou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Michel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pognant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Todesco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Migliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baudon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Boutin</surname></persName>
		</author>
		<idno type="DOI">10.1186/1475-2875-8-236</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cb9aGrw">Malaria Journal</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">236</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ollivier L., Romand O., Marimoutou C., Michel R., Pognant C., Todesco A., Migliani R., Baudon D. &amp; Boutin J.P. (2009) Use of short message service (SMS) to improve malaria chemoprophylaxis compliance after returning from a malaria endemic area. Malaria Journal 8, 236. doi:10.1186/1475-2875-8-236.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_g477MaF">Adherence to medication</title>
		<author>
			<persName><forename type="first">L</forename><surname>Osterberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Blaschke</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmra050100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_E6QaJfJ">New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="487" to="497" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osterberg L. &amp; Blaschke T. (2005) Adherence to medication. New England Journal of Medicine 353(5), 487-497. doi:10.1056/ NEJMra050100.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_vAX5UBV">Improving asthma control through telemedicine: a study of short-message service</title>
		<author>
			<persName><forename type="first">V</forename><surname>Ostojic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cvoriscec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Ostojic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Reznikoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stipic-Markovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tudjman</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2005.11.28</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AafTyxU">Telemedicine Journal and e-Health</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="28" to="35" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ostojic V., Cvoriscec B., Ostojic S.B., Reznikoff D., Stipic- Markovic A. &amp; Tudjman Z. (2005) Improving asthma control through telemedicine: a study of short-message service. Telemedicine Journal and e-Health 11(1), 28-35. doi:10.1089/ tmj.2005.11.28</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_2HgrT7F">Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study</title>
		<author>
			<persName><forename type="first">V</forename><surname>Pena-Robichaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Kvedar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Watson</surname></persName>
		</author>
		<idno type="DOI">10.1155/2010/894258</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uF7RMYn">Dermatology Research and Practice</title>
		<imprint>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2010">2010. 2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pena-Robichaux V., Kvedar J.C. &amp; Watson A.J. (2010) Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatology Research and Practice 2010, 1-6.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_c8U53Qd">A text message programme designed to modify patients&apos; illness and treatment beliefs improves self-reported adherence to asthma preventer medication</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Broadbent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weinman</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2044-8287.2011.02033.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ETMk8kZ">British Journal of Health Psychology</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="74" to="84" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Petrie K.J., Perry K., Broadbent E. &amp; Weinman J. (2012) A text message programme designed to modify patients&apos; illness and treatment beliefs improves self-reported adherence to asthma preventer medication. British Journal of Health Psychology 17 (1), 74-84. doi:10.1111/j.2044-8287.2011.02033.x.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<idno type="DOI">10.3133/fs20043149</idno>
		<ptr target="http://www.pewinternet.org/fact-sheets/mobile-technology-fact-sheet/on20" />
		<title level="m" xml:id="_NPyjuPy">Mobile Technology Fact Sheet</title>
		<imprint>
			<date type="published" when="2014-03">2014. March 2014</date>
		</imprint>
		<respStmt>
			<orgName>Pew Research Center</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Pew Research Center (2014) Mobile Technology Fact Sheet. Retrieved from http://www.pewinternet.org/fact-sheets/mobile- technology-fact-sheet/ on 20 March 2014.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_833Vg5h">Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pop-Eleches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thirumurthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Habyarimana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Zivin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Walque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mackeen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Haberer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kimaiyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sidle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ngare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Bangsberg</surname></persName>
		</author>
		<idno type="DOI">10.1097/qad.0b013e32834380c1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vsF65jg">Acquired Immune Deficiency Syndrome</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="825" to="834" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pop-Eleches C., Thirumurthy H., Habyarimana J.P., Zivin J.G., Goldstein M.P., de Walque D., MacKeen L., Haberer J., Kimaiyo S., Sidle J., Ngare D. &amp; Bangsberg D.R. (2011) Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. Acquired Immune Deficiency Syndrome 25(6), 825-834. doi:10.1097/QAD. 0b013e32834380c1.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main" xml:id="_X7R4WNy">Health behavior models in the age of mobile interventions: are our theories up to the task?</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Atienza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Nilsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Allison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mermelstein</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13142-011-0021-7</idno>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Riley W.T., Rivera D.E., Atienza A.A., Nilsen W., Allison S.M. &amp; Mermelstein R. (2011) Health behavior models in the age of mobile interventions: are our theories up to the task?</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
